Non-selective monoamine reuptake inhibitors

MRI_NONSEL

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N06AA 1 out of 7 registries used, show all original rules.	22204
4. Check minimum number of events Min. number of events 3	22204
5. Include endpoints None	22204
6. Filter based on genotype QC (FinnGen only)	19699

Control definitions (FinnGen only)

Control exclude: ANTIDEPRESSANTS

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	MRI_NONSEL
CONTROL_EXCLUDE	ANTIDEPRESSANTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N06AA
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Non-selective monoamine reuptake inhibitors based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	19699	12899	6800
Unadjusted period prevalence (%)	4.08	4.58	3.12
Median age at first event (years)	48.12	47.31	49.65

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
20250: Matched controls
194238

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M70.6

ICD-10 Finland

Trochanteric bursitis

2.2

322.7

3243

15519

P01AB01

ATC

metronidazole; oral, rectal

1.8

321.9

8233

53973

J01MA02

ATC

ciprofloxacin; systemic

1.8

321.2

8005

52073

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

318.3

8125

53182

EBA00

NOMESCO Finland

Extraction of tooth

1.8

317.5

7064

44395

R03BB04

ATC

tiotropium bromide; inhalant

2.5

315.7

2245

9246

2961E

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]

44.5

315.5

193

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

91.9

315.1

171

N05AC01

ATC

periciazine; systemic

27.9

315.0

219

N03AF02

ATC

oxcarbazepine; oral

4.3

312.1

836

1913

L17

ICPC

Foot/toe symptom/complaint

1.8

311.1

6451

39634

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

308.3

3525

17708

M02AA07

ATC

piroxicam; topical

1.9

307.7

7910

48568

N02BF01

ATC

gabapentin; oral

3.6

307.7

3040

9072

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.5

307.7

2284

9281

SPAT1307

SPAT

Psychosocial counselling and guidance

5.7

307.7

1070

1872

N06AA12

ATC

doxepin; systemic

90.8

307.7

6569

1022

A02BA04

ATC

nizatidine; systemic

3.2

307.7

2028

6553

P18

ICPC

Medication abuse

28.4

307.7

263

N05AF01

ATC

flupentixol; systemic

34.3

307.7

854

249

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.2

307.7

6046

30957

F34.1

ICD-10 Finland

Dysthymia

72.5

307.7

1583

227

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

15.2

307.7

842

552

M01AG02

ATC

tolfenamic acid; oral, rectal

2.5

307.7

3615

15414

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.8

307.7

2503

9193

N02CC07

ATC

frovatriptan; oral

4.3

307.7

1038

2392

A10BA02

ATC

metformin; oral

1.9

307.7

6030

35143

N03AF01

ATC

carbamazepine; oral, rectal

5.8

307.7

1864

3321

M01AC06

ATC

meloxicam; systemic, rectal

1.8

307.7

7728

49017

N03AX09

ATC

lamotrigine; oral

27.7

307.7

2201

851

R52.2

ICD-10 Finland

Other chronic pain

6.9

307.7

1428

2119

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

39.8

307.7

383

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.0

307.7

5982

34277

N06AX18

ATC

reboxetine; oral

114.3

307.7

579

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

11.5

307.7

379

321

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

58.7

307.7

194

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

11.7

307.7

2140

1946

F31

ICD-10 Finland

Bipolar affective disorder

36.4

307.7

398

107

N06AB04

ATC

citalopram; systemic

27.7

307.7

8686

5137

F51.0

ICD-10 Finland

Nonorganic insomnia

5.0

307.7

4606

10739

N06AA10

ATC

nortriptyline; systemic

46.1

307.7

2322

544

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.2

307.7

2134

6942

M79.7

ICD-10 Finland

Fibromyalgia

14.0

307.7

1748

1299

A06AC01

ATC

ispaghula (psylla seeds); oral

2.8

307.7

7049

30971

H03AA01

ATC

levothyroxine sodium; systemic

2.0

307.7

5175

28782

J01EA01

ATC

trimethoprim; systemic

1.9

307.7

5685

32918

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

23.1

307.7

964

419

P15

ICPC

Chronic alcohol abuse

7.6

307.7

685

896

IGY99

NOMESCO Finland

Other psychiatric treatment contact

21.2

307.7

489

226

N02BF02

ATC

pregabalin; oral

4.9

307.7

2182

4685

M01AE02

ATC

naproxen; oral, rectal

2.0

307.7

11836

79156

M03BC01

ATC

orphenadrine (citrate); systemic

2.3

307.7

5022

24459

188

Kela drug reimbursment

Psychosis requiring demanding treatment

18.1

307.7

356

192

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

39.0

307.7

277

G43.3

ICD-10 Finland

Complicated migraine

10.9

307.7

657

596

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

96.2

307.7

228

F10.20

ICD-10 Finland

Alcohol dependence currently independent

19.9

307.7

700

348

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

22.5

307.7

269

116

N03AE01

ATC

clonazepam; systemic

13.1

307.7

2973

2520

N05AH03

ATC

olanzapine; systemic

17.2

307.7

2643

1681

K59.0

ICD-10 Finland

Constipation

3.4

307.7

1498

4419

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

47.2

307.7

499

104

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

307.7

8404

45693

F60.5

ICD-10 Finland

Anankastic personality disorder

27.8

307.7

289

101

G44.2

ICD-10 Finland

Tension-type headache

2.8

307.7

3443

13028

M79.6

ICD-10 Finland

Pain in limb

1.9

307.7

9522

60966

R42

ICD-10 Finland

Dizziness and giddiness

2.0

307.7

5066

28142

F41.09

ICD-10 Finland

UNS Panic Syndrome

17.7

307.7

763

429

C03CA01

ATC

furosemide; systemic

2.1

307.7

6930

39051

A03FA01

ATC

metoclopramide; systemic, rectal

2.2

307.7

5293

26895

N02CC03

ATC

zolmitriptan; nasal, oral

3.6

307.7

1372

3875

L28

ICPC

Limited function/disability (L)

2.4

307.7

4652

21112

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

307.7

6761

40475

SPAT1254

SPAT

Administration of medicine

2.3

307.7

3085

13986

N05BA06

ATC

lorazepam; systemic, sublingual

11.0

307.7

2141

2071

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

4.5

307.7

906

1999

A01

ICPC

Pain general/multiple sites

3.3

307.7

2839

9101

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.9

307.7

1909

2870

N02CD01

ATC

erenumab; parenteral

13.6

307.7

330

237

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.2

307.7

1469

4685

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

10.4

307.7

2686

2807

N04AA02

ATC

biperiden; systemic

14.1

307.7

752

530

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

113.8

307.7

407

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

62.0

307.7

287

N04BC05

ATC

pramipexole; oral

3.5

307.7

2021

5907

SPAT1240

SPAT

Therapeutic discussion

6.3

307.7

2572

4387

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

20.6

307.7

271

128

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

19.3

307.7

297

150

V03AA01, ,

ATC

15.6

307.7

580

367

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

11.8

307.7

740

622

F41.00

ICD-10 Finland

Moderate panic disorder

35.2

307.7

449

125

F39

ICD-10 Finland

Unspecified mood [affective] disorder

15.2

307.7

396

255

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

24.2

307.7

602

246

J01DA01

ATC

[U] cefalexin

1.9

307.7

12645

91661

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

30.6

307.7

367

117

P06

ICPC

Sleep disturbance

3.6

307.7

3161

9406

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

3.1

307.7

1647

5382

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

3.0

307.7

3914

14406

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

12.2

307.7

442

355

N06AG02

ATC

moclobemide; oral

41.3

307.7

2147

556

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

12.0

307.7

466

379

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

76.6

307.7

182

N06AB05

ATC

paroxetine; oral

36.0

307.7

2448

739

N06AB03

ATC

fluoxetine; oral

29.7

307.7

5472

2392

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

14.9

307.7

298

194

N05CF01

ATC

zopiclone; oral

6.9

307.7

11122

29311

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

307.7

5332

29636

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

73.6

307.7

782

106

C07AB02

ATC

metoprolol; systemic

2.1

307.7

4441

23283

N05BA05

ATC

potassium clorazepate; oral

22.0

307.7

399

177

N05AF03

ATC

chlorprothixene; systemic

37.8

307.7

1549

425

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

58.1

307.7

210

F29

ICD-10 Finland

Unspecified nonorganic psychosis

10.7

307.7

1015

956

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

47.9

307.7

358

N06AA21

ATC

maprotiline; systemic

125.9

307.7

195

A02BC05

ATC

esomeprazole; systemic

2.2

307.7

9257

53974

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

4.2

307.7

1149

2763

30041

ICD-8 Finland

Neuroses, Depressiva

9.5

307.7

411

423

F32.8

ICD-10 Finland

Other depressive episodes

22.1

307.7

427

189

N02CD03

ATC

fremanezumab; systemic

12.1

307.7

344

276

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

179.2

307.7

240

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

109.1

307.7

1748

168

M79.0

ICD-10 Finland

Rheumatism, unspecified

13.3

307.7

1958

1553

N06AX11

ATC

mirtazapine; oral

13.4

307.7

11870

18616

M03BX01

ATC

baclofen; systemic

7.7

307.7

596

759

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.5

307.7

2884

12053

N05AX08

ATC

risperidone; systemic

7.2

307.7

2834

4296

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

17.1

307.7

433

248

G43.9

ICD-10 Finland

Migraine, unspecified

4.2

307.7

1537

3763

N05AL01

ATC

sulpiride; systemic

40.3

307.7

780

193

N06AX22

ATC

agomelatine; oral

102.9

307.7

774

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

60.0

307.7

938

157

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

8.9

307.7

2357

2838

AA400

NOMESCO Finland

Electroconvulsive therapy

129.8

307.7

346

F99

ICD-10 Finland

Mental disorder, not otherwise specified

11.8

307.7

519

433

F31.8

ICD-10 Finland

Other bipolar affective disorders

42.9

307.7

574

132

F41.1

ICD-10 Finland

Generalized anxiety disorder

16.5

307.7

1406

874

N02CC06

ATC

eletriptan; oral

4.9

307.7

1010

2042

N05AH04

ATC

quetiapine; oral

16.1

307.7

7231

6458

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

59.4

307.7

2746

512

A04

ICPC

Weakness/tiredness general

2.3

307.7

3320

14995

N05BA02

ATC

chlordiazepoxide; systemic

22.9

307.7

1107

490

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

8.4

307.7

592

697

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

4.6

307.7

1530

3407

N06CA01

ATC

amitriptyline and psycholeptics; systemic

9.5

307.7

4749

6092

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

19.6

307.7

459

229

M01AB55

ATC

diclofenac, combinations; oral

3.2

307.7

1869

5908

ZY010

NOMESCO Finland

Hospital outpatient

5.3

307.7

1203

2273

A01AB09

ATC

miconazole; local oral

2.7

307.7

2083

8026

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

307.7

4069

20093

Z2445

NOMESCO Finland

Psychologist

6.3

307.7

863

1371

F60.9

ICD-10 Finland

Personality disorder, unspecified

49.0

307.7

542

109

N05CD07

ATC

temazepam; oral

12.8

307.7

6206

6480

M01AX17

ATC

nimesulide; oral

2.1

307.7

5535

29159

P74

ICPC

Anxiety disorder/anxiety state

14.0

307.7

1148

830

N05AA02

ATC

levomepromazine; systemic

33.0

307.7

2602

864

N05BA04

ATC

oxazepam; oral

8.9

307.7

9496

17476

P76

ICPC

Depressive disorder

25.5

307.7

2023

841

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

19.4

307.7

422

213

AA1AD

NOMESCO Finland

CT of head and brain

2.1

307.7

6298

34424

N05BE01

ATC

buspirone; oral

58.3

307.7

1751

315

F33.8

ICD-10 Finland

Other recurrent depressive disorders

99.8

307.7

267

N06AX21

ATC

duloxetine; oral

22.8

307.7

5363

3017

P99

ICPC

Psychological disorders other

15.1

307.7

971

644

R03AC02

ATC

salbutamol; inhalant

2.0

307.7

11479

77110

N05CD02

ATC

nitrazepam; oral

15.1

307.7

863

570

N06AX03

ATC

mianserin; oral

48.5

307.7

2724

620

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.3

307.7

10091

58132

F33

ICD-10 Finland

Recurrent depressive disorder

49.3

307.7

550

110

N05AC02

ATC

thioridazine; oral

16.3

307.7

853

522

J02AC01

ATC

fluconazole; systemic

1.8

307.7

8272

53199

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

81.4

307.7

870

107

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

20.7

307.7

733

352

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

9.0

307.7

498

540

N05AD01

ATC

haloperidol; systemic

6.6

307.7

1017

1538

G47.3

ICD-10 Finland

Sleep apnoea

2.3

307.7

4911

24127

M01AE03

ATC

ketoprofen; systemic, rectal

2.4

307.7

8893

47970

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

17.2

307.7

358

203

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

32.5

307.7

218

A02BC01

ATC

omeprazole; systemic

2.5

307.7

6644

31808

N05CD08

ATC

midazolam; nasal, systemic

7.8

307.7

800

1018

F60.8

ICD-10 Finland

Other specific personality disorders

38.9

307.7

205

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

188.3

307.7

252

G04BD04

ATC

oxybutynin; oral, transdermal

3.5

307.7

1381

3994

R02

ICPC

Shortness of breath/dyspnoea

2.3

307.7

3103

14163

N05BA01

ATC

diazepam; systemic, rectal

9.7

307.7

5878

7834

IGY02

NOMESCO Finland

Psychiatric monitoring contact

16.2

307.7

788

484

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

21.5

307.7

538

246

P01

ICPC

Feeling anxious/nervous/tense

6.2

307.7

2695

4701

M01AH01

ATC

celecoxib; oral

2.5

307.7

4599

20707

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

3.2

307.7

3272

11169

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

105.2

307.7

534

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

76.3

307.7

839

110

R06AE07

ATC

cetirizine; oral

1.8

307.7

8872

59065

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

154.1

307.7

979

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

13.6

307.7

1157

862

K59.09

ICD-10 Finland

Constipation, unspecified

3.1

307.7

1735

5616

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

38.4

307.7

210

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

307.7

6983

35691

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

63.4

307.7

678

106

F32.9

ICD-10 Finland

Depressive episode, unspecified

23.3

307.7

4827

2575

N03AX16

ATC

[U] pregabalin

5.5

307.7

8398

22220

N06AX16

ATC

venlafaxine; oral

45.4

307.7

6287

1907

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

26.7

307.7

286

104

M54.5

ICD-10 Finland

Low back pain

2.3

307.7

8351

45835

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

24.9

307.7

2788

1240

N06AA09

ATC

amitriptyline; systemic

71.5

307.7

12104

3954

F40.1

ICD-10 Finland

Social phobias

25.4

307.7

536

208

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

24.2

307.7

420

170

N06AA06

ATC

trimipramine; systemic

105.2

307.7

2670

280

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

80.3

307.7

199

N02AX02

ATC

tramadol; systemic, rectal

3.2

307.7

11412

56203

N02CC04

ATC

rizatriptan; oral

3.5

307.7

1441

4161

A02BA02

ATC

ranitidine; systemic

2.9

307.7

5129

20559

N05AB01

ATC

dixyrazine; systemic

26.6

307.7

604

224

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

51.3

307.7

285

F10.24

ICD-10 Finland

Alcohol depence active use

15.8

307.7

443

274

P72

ICPC

Schizophrenia

10.1

307.7

515

499

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.9

307.7

2665

9527

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

32.3

307.7

690

212

3007

Kela drug reimbursment

Erenumab and fremanezumab

11.2

307.7

483

422

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.3

307.7

5206

11895

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

31.3

307.7

472

148

N06AX26

ATC

vortioxetine; oral

46.0

307.7

2153

501

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

36.4

307.7

1059

294

F60.7

ICD-10 Finland

Dependent personality disorder

68.8

307.7

206

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

111.4

307.7

652

IHZ05, ,

SPAT

8.1

307.7

869

1064

C07AB07

ATC

bisoprolol; oral

2.1

307.7

10805

68687

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

23.2

307.7

394

166

A02BC03

ATC

lansoprazole; oral

2.5

307.7

7106

34524

Z2446

NOMESCO Finland

Social worker

3.8

307.7

1471

3944

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.7

307.7

2281

8633

M48.0

ICD-10 Finland

Spinal stenosis

2.8

307.7

3271

12400

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

28.8

307.7

499

170

F20.9

ICD-10 Finland

Schizophrenia, unspecified

10.4

307.7

621

587

N05CF02

ATC

zolpidem; oral

5.2

307.7

5396

12594

M54.4

ICD-10 Finland

Lumbago with sciatica

2.6

307.7

4587

19743

M01AH02

ATC

rofecoxib; oral

2.5

307.7

3236

13531

N06AB10

ATC

escitalopram; oral

18.0

307.7

5705

4147

E66.01

ICD-10 Finland

Obesity due to excess calories

2.7

307.7

2044

7887

N05BA12

ATC

alprazolam; oral

12.1

307.7

4166

4056

N03AX12

ATC

[U] gabapentin; oral

5.5

307.7

6017

13806

N06AX05

ATC

trazodone; oral

89.8

307.7

1298

148

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

34.9

307.7

1122

326

P03

ICPC

Feeling depressed

10.5

307.7

2556

2629

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

27.9

307.7

1382

508

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

104.0

307.7

2257

234

N06AB08

ATC

fluvoxamine; oral

52.5

307.7

1245

242

N05AE04

ATC

ziprasidone; systemic

51.5

307.7

202

F32

ICD-10 Finland

Depressive episode

16.4

307.7

1362

850

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

12.6

307.7

482

374

M03BC51

ATC

orphenadrine, combinations; systemic

2.1

307.7

6001

32030

N06AB06

ATC

sertraline; oral

36.6

307.7

4416

1467

A03FA02

ATC

cisapride; oral, rectal

3.3

307.7

2049

6356

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

8.3

307.7

2637

3445

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

89.7

307.7

222

N02CC05

ATC

almotriptan; oral

4.2

307.7

1035

2433

N03AG01

ATC

valproic acid; systemic, rectal

11.3

307.7

2573

2464

R52.1

ICD-10 Finland

Chronic intractable pain

15.9

307.7

412

254

T36

ICD-10 Finland

Poisoning by systemic antibiotics

22.5

307.7

1845

863

R06.0

ICD-10 Finland

Dyspnoea

2.2

307.7

6245

32771

A03CA02

ATC

clidinium and psycholeptics; oral

4.2

307.7

1759

4264

N07BB01

ATC

disulfiram; oral

12.1

307.7

1307

1105

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

307.7

4350

21228

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

15.7

307.7

344

213

A02BC02

ATC

pantoprazole; systemic

2.3

307.7

14802

105579

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

307.7

5901

34694

R52.9

ICD-10 Finland

Pain, unspecified

2.4

307.7

2453

10348

N06AX12

ATC

bupropion; oral

40.7

307.7

2222

587

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

6.2

307.7

723

1156

M03BX02

ATC

tizanidine; oral

2.1

307.7

13070

90462

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

113.4

307.7

597

N03AX11

ATC

topiramate; oral

15.0

307.7

1193

808

N05AD03

ATC

melperone; systemic

12.8

307.7

559

431

F10.25

ICD-10 Finland

Alcohol dependence continuous use

13.2

307.7

517

385

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

19.3

307.7

845

437

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

269.0

307.7

439

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

307.7

4077

19548

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

307.7

3319

14890

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

307.7

8887

56397

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

18.0

307.7

3424

2170

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

307.7

5521

31079

N02AA05

ATC

oxycodone; systemic

2.4

307.7

4360

19674

A06AD11

ATC

lactulose; oral

3.9

307.7

4569

13515

N05AX12

ATC

aripiprazole; systemic

29.8

307.7

1480

513

N05AA01

ATC

chlorpromazine; systemic, rectal

18.6

307.7

569

302

R11

ICD-10 Finland

Nausea and vomiting

2.7

307.7

1982

7414

L03

ICPC

Low back symptom/complaint

2.1

307.7

6407

34953

P29

ICPC

Psychological sympt/compl other

7.3

307.7

1876

2673

R51.80

ICD-10 Finland

Headache

3.0

307.7

3895

14297

M01AB05

ATC

diclofenac; systemic, rectal

1.9

307.7

13489

100583

F43.1

ICD-10 Finland

Post-traumatic stress disorder

9.4

307.7

540

565

F61

ICD-10 Finland

Mixed and other personality disorders

59.2

307.7

226

C07AA05

ATC

propranolol; systemic

4.2

307.7

5823

17041

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

307.7

6240

35101

F41.8

ICD-10 Finland

Other specified anxiety disorders

7.0

307.7

574

810

F32.1

ICD-10 Finland

Moderate depressive episode

14.4

307.7

1467

1049

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

144.5

307.7

253

N05AH02

ATC

clozapine; systemic

17.6

307.7

637

357

IGY02, ,

SPAT

18.2

307.7

448

241

N06AX17

ATC

milnacipran; oral

138.3

307.7

520

N06AA22, ,

ATC

141.6

307.7

671

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

78.3

307.7

226

IHZ04, ,

SPAT

12.2

307.7

399

319

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.0

307.7

6048

34304

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

3.5

307.7

2354

7103

R53

ICD-10 Finland

Malaise and fatigue

2.5

307.7

5735

26350

H02AB06

ATC

prednisolone; systemic

1.9

307.7

10161

67587

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.0

307.7

1699

5678

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

210.4

307.7

2227

114

N06AA04

ATC

clomipramine; systemic

166.5

307.7

2157

139

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

15.8

307.7

492

305

SPAT1243

SPAT

Psychiatric/psychological examination

11.0

307.7

523

465

N05AB03

ATC

perphenazine; systemic, rectal

23.4

307.7

1820

818

A28

ICPC

Limited function/disability NOS

2.1

307.7

3862

19401

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

28.5

307.7

238

N02AC04

ATC

dextropropoxyphene; oral

5.0

307.7

1273

2588

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

9.9

307.7

552

547

N06BA04

ATC

methylphenidate; oral

9.4

307.7

449

466

N05AN01

ATC

lithium; oral

31.0

307.7

1108

362

F61.0

ICD-10 Finland

Mixed personality disorders

67.5

307.7

739

109

E66.8

ICD-10 Finland

Other obesity

3.3

307.2

1242

3776

M03AX01

ATC

botulinum toxin; parenteral

8.1

306.8

424

514

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

305.8

5661

33547

M25.5

ICD-10 Finland

Pain in joint

1.8

304.6

6823

42842

J01FF01

ATC

clindamycin; systemic

1.9

303.9

5622

33298

SPAT1234

SPAT

Support of social functional capacity

3.4

303.8

1172

3460

UJF32

NOMESCO Finland

Coloscopy

1.9

303.7

5569

32891

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

25.3

301.9

217

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

301.0

9631

66864

SPAT1216

SPAT

Assessment of functional ability

2.1

300.7

3250

15966

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

300.0

3591

18333

ZY000

NOMESCO Finland

Hospital inpatient

12.6

299.9

301

233

N02BE01

ATC

paracetamol; systemic, rectal

2.3

299.8

18132

152476

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

17.1

299.7

254

144

N05AB02

ATC

fluphenazine; systemic

17.6

298.8

250

138

F41.3

ICD-10 Finland

Other mixed anxiety disorders

12.4

297.5

301

236

T90

ICPC

Diabetes non-insulin dependent

1.9

297.0

5136

29741

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

295.3

4780

27085

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

3.2

295.3

1285

4082

F10.09

ICD-10 Finland

Alcohol intoxication UNS

6.8

294.1

474

684

E0000UV, ,

ATC

1.7

293.9

8379

56225

Z3226

NOMESCO Finland

Physiotherapist

2.0

293.8

3664

18974

N05CD05

ATC

triazolam; oral, sublingual

7.5

292.9

428

554

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.7

291.3

983

2657

N05AF05

ATC

zuclopenthixol; systemic

11.1

290.8

315

275

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

11.3

290.3

311

267

P16

ICPC

Acute alcohol abuse

9.2

289.7

361

384

F90.0

ICD-10 Finland

Disturbance of activity and attention

7.5

289.0

425

554

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

19.2

289.0

232

117

N01

ICPC

Headache

2.5

288.8

2074

8564

N89

ICPC

Migraine

4.5

288.8

725

1576

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

288.7

8985

61668

A02BX02

ATC

sucralfate; oral

3.5

287.9

1038

2932

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.4

285.7

1075

3121

SPAT1301

SPAT

No procedures

1.8

284.7

6131

37889

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

283.9

4085

22217

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

282.1

3533

18297

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.2

280.6

2754

13000

G04BD07

ATC

tolterodine; oral

3.2

280.4

1177

3657

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

5.9

279.3

521

872

IGV01

NOMESCO Finland

Psychiatric network contact

20.3

278.2

218

104

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

277.6

5325

31739

Z3231

NOMESCO Finland

Registered nurse

1.8

275.7

5320

31757

M01AE51

ATC

ibuprofen, combinations; systemic

5.7

274.8

525

899

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

273.6

4049

22198

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

11.2

273.5

296

258

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

41.1

272.9

170

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

21.9

271.3

206

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

37.2

270.8

173

UKC02

NOMESCO Finland

Cystoscopy

2.1

270.7

3208

16261

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.0

270.6

1253

4123

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.0

270.0

3450

17969

F32.0

ICD-10 Finland

Mild depressive episode

6.5

269.6

454

686

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

267.5

9045

63046

P80

ICPC

Personality disorder

46.1

266.8

162

L86

ICPC

Back syndrome with radiating pain

2.8

265.8

1459

5269

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.8

265.3

5067

30095

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

15.9

265.2

233

142

N02CC02

ATC

naratriptan; oral

5.2

265.0

558

1045

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

264.2

4999

29600

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.8

264.0

1423

5089

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.2

263.9

2700

12935

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.0

261.2

1235

4110

V03AB30, ,

ATC

18.3

261.1

214

113

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.1

260.3

2938

14608

H02AB07

ATC

prednisone; oral

2.1

260.3

2959

14752

IAB01, ,

SPAT

34.3

260.3

170

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

259.9

10659

77883

SPAT1229

SPAT

Assessment of need for aid

2.6

259.3

1701

6717

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

258.1

7291

48327

J01AA02

ATC

doxycycline; systemic

1.8

258.0

15723

127603

N02CX04, ,

ATC

4.5

256.9

647

1409

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

255.1

1577

6048

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

12.9

255.0

252

190

IGY99, ,

SPAT

9.4

254.4

310

320

N05BB01

ATC

hydroxyzine; systemic

2.8

253.3

1376

4939

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

43.1

253.1

156

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

252.8

13712

107330

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

252.7

2828

14004

N30.0

ICD-10 Finland

Acute cystitis

1.9

252.2

3688

20076

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

42.8

251.1

155

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

25.8

250.8

179

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

250.1

3796

20914

A07AA02

ATC

nystatin; oral

2.7

249.6

1406

5142

L01

ICPC

Neck symptom/complaint

2.0

249.5

3322

17509

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

3.9

249.0

776

1983

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

19.6

248.6

198

S06.0

ICD-10 Finland

Concussion

2.3

248.0

2162

9692

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

34.0

247.6

162

G43

ICD-10 Finland

Migraine

3.2

247.6

1033

3194

M54.1

ICD-10 Finland

Radiculopathy

3.3

247.5

982

2944

M47.9

ICD-10 Finland

Spondylosis, unspecified

3.6

246.8

855

2349

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

4.3

245.2

665

1534

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

11.4

245.0

261

222

G04BD12

ATC

mirabegron; oral

2.1

243.9

2513

12048

M01AX01

ATC

nabumetone; oral

3.1

243.8

1070

3409

SPAT1263

SPAT

Sampling

1.7

243.3

7893

54019

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.0

242.8

2927

14881

J01FA06

ATC

roxithromycin; oral

1.7

241.6

7856

53772

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

240.2

13656

107410

SPAT1262

SPAT

Handing over of treatment supplies

1.9

238.6

3442

18618

Z08

ICPC

Social welfare problem

7.6

238.2

344

439

N06AC02, ,

ATC

29.5

237.4

162

G04BD08

ATC

solifenacin; oral

2.6

236.6

1464

5611

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

235.8

1583

6311

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

57.5

235.7

137

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

9.0

234.8

295

317

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

37.2

234.7

150

K02.1

ICD-10 Finland

Caries of dentine

1.6

234.7

10974

81971

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.8

234.6

547

1118

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.2

234.6

2295

10771

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.4

234.4

1868

8050

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

51.6

234.4

139

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.3

233.6

1993

8844

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

233.4

4491

26578

SFA10

NOMESCO Finland

One-surface restoration

1.6

232.5

10405

76824

M79.1

ICD-10 Finland

Myalgia

2.0

232.5

2982

15480

M47.82

ICD-10 Finland

Other spondylosis, cervical region

3.2

232.2

1000

3149

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

231.4

2193

10159

E000001, ,

ATC

1.9

230.6

3825

21621

M02AA10

ATC

ketoprofen; topical

1.9

229.8

3419

18659

M89.0

ICD-10 Finland

Algoneurodystrophy

8.8

229.8

295

326

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.2

229.6

956

2950

D12

ICPC

Constipation

3.4

229.0

886

2613

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

12.1

228.5

234

187

F41.01

ICD-10 Finland

Severe panic disorder

50.5

228.3

136

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

18.0

227.5

188

101

Z71.8

ICD-10 Finland

Other specified counselling

1.7

225.4

6493

42892

M54.3

ICD-10 Finland

Sciatica

2.6

224.8

1387

5304

Z72.2

ICD-10 Finland

Drug use

25.8

224.0

160

B18.2

ICD-10 Finland

Chronic viral hepatitis C

9.7

224.0

266

265

F22.0

ICD-10 Finland

Delusional disorder

6.4

223.7

379

576

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

223.0

2567

12804

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

35.7

222.9

144

N06AA02

ATC

imipramine; systemic

89.8

222.2

121

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

13.5

221.7

213

153

A01AB04

ATC

amphotericin B; local oral

2.9

221.5

1132

3926

R05FB02

ATC

cough suppressants and expectorants; systemic

1.6

219.7

7405

50808

IEY01

NOMESCO Finland

Psychoeducation, individual

24.8

219.5

159

J01DB01

ATC

cefalexin; oral

1.8

219.5

16185

134469

SPAT1260

SPAT

Consultation of another employee

1.9

219.0

3410

18859

T82

ICPC

Obesity

3.2

218.5

905

2783

F21

ICD-10 Finland

Schizotypal disorder

19.2

218.2

175

R01BA52

ATC

pseudoephedrine, combinations; oral

1.7

218.2

6003

39114

R35

ICD-10 Finland

Polyuria

2.6

217.9

1415

5546

F45.0

ICD-10 Finland

Somatization disorder

20.7

217.4

169

M01AB51

ATC

indometacin, combinations; oral, rectal

4.1

217.1

612

1453

IER01

NOMESCO Finland

Psychoeducation, group

24.9

217.0

157

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

216.9

5200

32654

D07AA02

ATC

hydrocortisone; topical

2.0

216.6

2645

13469

R5140

NOMESCO Finland

Monitoring the use of the aid

2.2

216.4

2167

10246

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

9.9

216.4

254

249

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

9.1

215.9

269

286

R96

ICPC

Asthma

2.2

215.4

2123

9976

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.0

215.0

1013

3358

N07BC02

ATC

methadone; systemic

20.7

214.9

167

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.3

214.7

1802

7928

H02AB04

ATC

methylprednisolone; systemic

1.9

214.6

3039

16283

J01MA12

ATC

levofloxacin; systemic

1.8

213.2

3679

20996

G47.9

ICD-10 Finland

Sleep disorder, unspecified

4.0

213.1

626

1532

R33

ICD-10 Finland

Retention of urine

2.4

213.0

1553

6423

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.4

212.9

818

2401

K59.1

ICD-10 Finland

Functional diarrhoea

2.7

211.2

1218

4500

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.4

210.7

814

2397

R03DC03

ATC

montelukast; oral

1.9

210.1

3255

17949

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

209.9

12360

96341

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

37.0

209.4

134

R03BA02

ATC

budesonide; inhalant

1.8

208.9

3514

19884

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

9.7

208.3

248

WX290

NOMESCO Finland

Other blockage of nerve

1.6

208.2

8383

59804

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

208.0

3616

20666

D11

ICPC

Diarrhoea

2.1

207.7

2210

10687

K07.60

ICD-10 Finland

Snapping jaw

2.8

207.7

1073

3741

A02BA03

ATC

famotidine; systemic

3.1

207.4

895

2819

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

51.6

207.3

123

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.9

207.3

1034

3537

L02

ICPC

Back symptom/complaint

2.2

207.3

2056

9677

F51

ICD-10 Finland

Nonorganic sleep disorders

3.5

206.2

756

2153

N06AC01, ,

ATC

106.1

205.7

110

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.7

205.4

1152

4194

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

204.6

4279

25809

J01CA08

ATC

pivmecillinam; oral

1.6

204.3

8224

58585

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

203.7

2219

10822

M54.2

ICD-10 Finland

Cervicalgia

2.3

203.3

1706

7499

M01AH05

ATC

etoricoxib; oral

1.6

202.5

12169

94907

U04

ICPC

Incontinence urine

2.6

202.3

1259

4829

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

62.2

202.2

116

A06AC51

ATC

ispaghula, combinations; oral

2.8

202.0

1064

3748

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

5.9

201.9

373

618

F60.0

ICD-10 Finland

Paranoid personality disorder

35.9

201.5

130

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

19.1

201.4

162

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

201.2

7070

48732

D07AC01

ATC

betamethasone; topical

1.6

201.1

7108

49058

D01

ICPC

Abdominal pain/cramps general

2.0

199.7

2345

11751

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.6

199.4

674

1819

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

199.4

7061

48730

F34.9

ICD-10 Finland

Persistent mood [affective] disorder, unspecified

33.3

198.9

131

R60.0

ICD-10 Finland

Localized oedema

1.9

198.7

2707

14287

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.2

198.3

834

2586

P25

ICPC

Phase of life problem adult

3.5

197.8

713

2008

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

197.5

2914

15791

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

196.8

5706

37482

R01AD09

ATC

mometasone; nasal

1.6

196.2

8468

61116

P28

ICPC

Limited function/disability (P)

10.9

193.7

213

190

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.8

193.7

1003

3499

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.0

193.5

2369

12043

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

8.4

193.4

256

294

R01AD08

ATC

fluticasone; nasal

1.6

193.2

5362

34805

S18

ICPC

Laceration/cut

1.6

193.1

9150

67357

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

192.7

7140

49701

G50.1

ICD-10 Finland

Atypical facial pain

4.4

192.6

496

1098

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

6.8

192.4

306

435

R13

ICD-10 Finland

Dysphagia

2.4

192.3

1475

6231

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.5

192.1

687

1925

P20

ICPC

Memory disturbance

1.9

190.8

2619

13845

ICB06, ,

NOMESCO Finland

26.9

190.5

134

P73

ICPC

Affective psychosis

23.7

190.2

140

WX308

NOMESCO Finland

Sacral anesthesy

15.2

190.1

171

109

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

189.9

1506

6455

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

189.7

4739

29911

M01AC01

ATC

piroxicam; systemic, rectal

1.9

189.5

2705

14484

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

189.2

3644

21406

K10.3

ICD-10 Finland

Alveolitis of jaws

2.9

189.1

958

3302

E66.00

ICD-10 Finland

Metabolic syndrome

2.6

188.0

1174

4507

N02CA52

ATC

ergotamine, combinations excl. psycholeptics; oral

4.6

187.0

459

978

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

186.9

1901

9018

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

185.8

9698

72695

WZA90

NOMESCO Finland

Other medical or dental certificate

1.7

185.8

4288

26480

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

185.5

2585

13724

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

185.4

2075

10203

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.7

185.3

4813

30659

P27

ICPC

Fear of mental disorder

8.9

185.1

235

256

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

19.9

184.7

146

IBA01, ,

SPAT

6.3

184.5

319

495

SPAT1310

SPAT

Counselling related to known health issue

1.6

184.3

5716

38052

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

183.4

12245

96696

N07BA03

ATC

varenicline; oral

2.9

183.4

922

3164

R03BA01

ATC

beclometasone; inhalant

1.9

183.0

2795

15285

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.2

182.5

746

2273

R07.3

ICD-10 Finland

Other chest pain

2.0

181.3

2115

10553

C10AA01

ATC

simvastatin; oral

1.5

181.1

7912

56945

XKC03

NOMESCO Finland

Water cystometry

3.4

180.9

689

2009

K08.3

ICD-10 Finland

Retained dental root

2.2

180.9

1608

7227

SFA30

NOMESCO Finland

Three-surface restoration

1.5

180.5

8109

58709

IBA03

NOMESCO Finland

Psychotherapy evaluation

18.0

180.3

149

ZYC01

NOMESCO Finland

Remote contact by phone

2.5

179.9

1237

4969

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.8

179.7

979

3507

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

10.6

179.6

201

184

N05AX15

ATC

cariprazine; oral

45.7

179.1

109

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.4

179.1

1316

5450

M01AH03

ATC

valdecoxib; oral

2.4

179.0

1338

5583

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

20.0

179.0

141

Z50.7

ICD-10 Finland

Occupational therapy and vocational rehabilitation, not elsewhere classified

11.4

178.8

190

161

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.9

178.7

896

3070

Z00.0

ICD-10 Finland

General medical examination

1.7

178.5

3678

21985

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

178.3

2243

11491

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

177.8

6619

45910

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

19.3

177.4

142

F20.0

ICD-10 Finland

Paranoid schizophrenia

10.9

177.2

194

172

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

14.6

176.7

162

107

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

176.5

2605

14079

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

176.3

3177

18263

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

253.7

176.0

183

R41.0

ICD-10 Finland

Disorientation, unspecified

3.4

175.8

673

1969

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.7

175.1

966

3482

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

175.0

2528

13565

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

11.8

174.2

181

148

P19

ICPC

Drug abuse

10.8

174.1

192

172

C05AA08

ATC

fluocortolone; rectal, topical

1.9

174.0

2667

14585

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

173.8

2057

10310

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

63.6

173.1

309

Kela drug reimbursment

Nalmefene and naltrexone

30.5

173.1

117

ZXY60

NOMESCO Finland

2-person team, nurses

25.5

172.9

124

R03BA05

ATC

fluticasone; inhalant

1.8

172.6

3414

20152

N05AA03

ATC

promazine; systemic

47.7

172.5

104

F20

ICD-10 Finland

Schizophrenia

12.2

172.3

176

140

R51

ICD-10 Finland

Headache

2.6

172.0

1095

4240

R15

ICD-10 Finland

Faecal incontinence

3.2

171.7

695

2104

SPAT1252

SPAT

Overall medication plan or its review

2.3

171.7

1354

5782

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

171.6

2586

14059

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.8

171.3

940

3378

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

170.9

4497

28650

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

4.0

170.7

503

1233

SPAT1241

SPAT

Extensive assessment of psychosocial situation

10.0

170.6

198

191

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

9.5

170.6

206

210

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.4

170.4

1238

5097

M01AB01

ATC

indometacin; systemic, rectal

2.2

170.2

1495

6680

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

170.0

5122

33739

TAB20

NOMESCO Finland

Epidural puncture

6.4

169.7

285

429

R03AC03

ATC

terbutaline; inhalant

1.9

169.2

2647

14558

N05AX16

ATC

brexpiprazole; oral

43.6

169.1

104

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

37.2

169.0

108

U02

ICPC

Urinary frequency/urgency

1.8

168.9

2986

17049

J01DA09

ATC

[U] cefadroxil

1.6

168.4

4970

32562

L08

ICPC

Shoulder symptom/complaint

1.6

168.3

4529

29003

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

167.2

1763

8464

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

167.1

4712

30518

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

4.1

167.0

466

1097

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

65.4

166.9

C08DA01

ATC

verapamil; systemic

2.7

166.7

936

3403

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.4

166.3

1210

4985

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.7

165.8

932

3391

R05

ICPC

Cough

1.6

165.6

4751

30891

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

9.4

165.4

202

209

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

86.7

164.4

R1250

NOMESCO Finland

Evaluation of functional capability

3.5

164.4

577

1596

E66.9

ICD-10 Finland

Obesity, unspecified

3.1

164.3

723

2300

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

164.0

1585

7357

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

163.9

1639

7708

-1, ,

NOMESCO Finland

1.6

163.8

5657

38414

Z01.2

ICD-10 Finland

Dental examination

1.5

163.7

8555

63536

30188

ICD-8 Finland

Personality disorders, Alia definita

15.6

163.4

145

SPAT1235

SPAT

Mental health, emotional support

13.3

163.2

158

115

KMAK, ,

NOMESCO Finland

1.5

162.9

9125

68723

XKD06

NOMESCO Finland

Physiologic investigation of micturition

3.4

162.2

594

1689

A07DA03

ATC

loperamide; oral

3.0

161.7

768

2552

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.4

161.3

1163

4770

F45.8

ICD-10 Finland

Other somatoform disorders

2.4

161.1

1201

5000

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

5.2

160.9

336

624

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

160.5

3015

17500

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

6.8

160.5

256

365

F34.0

ICD-10 Finland

Cyclothymia

33.0

160.5

106

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

160.4

2574

14254

SPAT1053

SPAT

Memory test

1.8

160.2

2526

13911

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

160.1

7455

53979

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.7

160.0

942

3508

A02BC04

ATC

rabeprazole; oral

2.1

159.5

1724

8347

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

159.3

890

3227

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

159.3

5014

33284

M35.7

ICD-10 Finland

Hypermobility syndrome

5.4

158.6

320

576

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

66.7

158.5

N02CD02

ATC

galcanezumab; parenteral

13.3

158.3

153

111

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8112

52955

1.78

321.73

3.7

3.2

32.68

33.90

u/l

0.72

7575

50045

(3023368) Bacteria identified in Blood by Culture

6983

43888

1.80

312.64

5.2

4.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

10385

73156

1.74

312.24

3.6

3.0

110.91

134.13

ug/l

15.78

9502

68396

(3031040) Bacteria [#/volume] in Urine by Automated count

13845

105907

1.80

311.13

6.8

4.4

2597.98

1860.49

e6/l

0.55

223

1426

(1001926) Buprenorphine [Presence] in Urine by Screen method

888

2142

4.11

309.22

3.8

1.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

10556

74860

1.74

308.35

2.8

2.4

78.83

78.68

nmol/l

0.20

9517

67788

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

12164

82947

2.02

307.65

7.7

7.2

1.21

1.22

mmol/l

1.22

10524

71618

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

10741

70726

1.97

307.65

2.5

2.0

97.43

96.55

pmol/l

0.98

5669

36573

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

484

264

17.99

307.65

14.2

13.5

846.97

797.39

nmol/l

0.76

468

251

(3013115) Eosinophils [#/volume] in Blood

11880

85431

1.81

307.65

8.1

6.4

0.19

e9/l

0.03

10496

74373

(3013826) Glucose [Moles/volume] in Serum or Plasma

13004

95582

1.85

307.65

6.2

4.7

6.81

6.72

mmol/l

4.54

12463

90780

(3024561) Albumin [Mass/volume] in Serum or Plasma

10786

73623

1.87

307.65

5.0

35.44

35.53

g/l

0.88

10067

68969

(3024666) Lithium [Moles/volume] in Serum or Plasma

413

180

22.45

307.65

12.5

16.3

0.62

0.67

mmol/l

1.55

376

165

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

7036

40417

2.03

307.65

2.7

2.3

2.92

2.89

mg/l

0.39

6102

35050

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

12287

86530

1.92

307.65

6.4

6.7

9.85

11.72

umol/l

60.14

11649

82647

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5693

32310

1.96

307.65

1.9

1.7

33369211.36

38735454.31

pmol/l

0.26

4705

26862

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

501

288

17.08

307.65

19.5

19.7

3387.84

1389.29

nmol/l

0.53

483

275

(3021960) Folate [Moles/volume] in Serum or Plasma

7549

44108

2.02

307.65

1.9

1.6

21.10

20.32

nmol/l

3.87

6462

37119

(3019309) Folate [Moles/volume] in Red Blood Cells

5171

24823

2.34

307.65

1.9

1.7

1192.87

1148.88

nmol/l

2.53

3939

18733

(3026008) Bacteria identified in Urine by Culture

7880

50481

1.81

307.65

4.3

3.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

868

1613

5.35

307.65

5.3

1.8

—

(3019198) Lymphocytes [#/volume] in Blood

11766

84424

1.80

307.65

7.7

6.3

1.94

1.91

e9/l

1.07

10453

74118

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

8039

49620

1.92

307.65

2.6

2.1

218.73

191.23

u/l

1.49

7613

46822

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

10864

73807

1.89

307.65

7.1

6.5

1.21

mmol/l

0.04

10027

68273

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1478

4223

3.54

307.65

1.9

1.5

0.30

0.31

mg/l

0.15

671

1878

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

15977

126266

2.01

307.65

9.5

8.2

80.63

79.73

u/l

1.55

15264

119932

(3009466) Valproate [Moles/volume] in Serum or Plasma

854

1134

7.50

307.65

5.9

4.5

360.39

360.30

umol/l

0.01

755

981

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2941

13313

2.31

307.65

2.3

2.4

353.65

383.99

nmol/l

12.24

2705

12442

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

8334

51103

1.96

307.65

3.1

2.6

54.17

77.15

u/l

1.24

7661

47531

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3330

13871

2.56

307.65

2.2

1.5

1.56

1.40

27.43

2871

12204

(3001604) Monocytes [#/volume] in Blood

11566

82578

1.80

307.65

7.6

6.3

0.59

e9/l

1.16

10057

70830

(3028707) Methadone [Presence] in Urine by Screen method

748

559

13.29

307.65

3.9

2.3

—

(3006315) Basophils [#/volume] in Blood

11609

82825

1.81

307.65

7.6

6.3

0.04

e9/l

0.16

10092

71040

(3015377) Calcium [Moles/volume] in Serum or Plasma

8439

56276

1.75

306.46

3.0

3.7

2.35

2.36

mmol/l

2.46

7613

51029

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

15674

124823

1.90

305.80

5.7

4.3

14.73

14.92

pmol/l

17.13

14495

114727

(3018418) pH of Serum or Plasma

7586

49383

1.76

297.36

4.3

4.4

7.40

1.09

5603

35174

(3013650) Neutrophils [#/volume] in Blood by Automated count

12481

93290

1.74

296.47

12.0

9.6

4.29

4.08

e9/l

17.14

11030

80694

(3022096) Basophils/Leukocytes in Blood

10594

76075

1.70

287.51

7.9

6.6

0.67

0.69

3.36

9916

71336

(3006504) Eosinophils/Leukocytes in Blood

10588

76026

1.70

287.38

7.7

6.5

2.74

2.85

5.37

9920

71334

(3019069) Monocytes/Leukocytes in Blood

10608

76228

1.70

286.91

7.9

6.6

8.65

8.91

17.83

9942

71563

(3037467) Urinalysis macro (dipstick) panel - Urine

14207

110899

1.77

281.12

6.2

4.5

1.66

72.26

0.50

190

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

15235

121396

1.82

280.87

5.5

4.4

13.45

12.58

mm/h

10.62

14294

113659

(3018010) Neutrophils/Leukocytes in Blood

10606

76503

1.69

280.09

7.6

6.4

57.70

57.41

1.77

10103

73099

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4559

25994

1.88

273.28

2.2

1.9

—

(3002030) Lymphocytes/Leukocytes in Blood

10732

78005

1.68

272.11

7.8

6.5

27.58

27.65

0.25

10165

74016

(3032080) INR in Blood by Coagulation assay

10545

76708

1.66

262.77

13.9

14.9

1.20

1.26

inr

35.37

8922

63720

(4198724) Urine methamphetamine measurement

251

181

13.46

260.73

2.2

2.6

—

(3016879) Cocaine [Presence] in Urine

953

2761

3.42

253.71

3.8

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

8870

62146

1.66

252.20

4.8

3.6

87.60

51.01

ng/l

0.34

6501

43579

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5533

34634

1.73

237.25

1.4

1.3

1.40

1.81

u/ml

1.64

1423

9446

(40768797) Stomach Pathology biopsy report

3904

22128

1.86

233.73

1.3

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

8231

57348

1.63

233.57

3.7

3.4

6.94

7.25

mmol/l

8.48

6869

48574

(3000764) Benzodiazepines [Presence] in Urine

981

3055

3.19

232.08

3.8

1.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4480

26662

1.79

227.69

3.0

3.4

0.82

mmol/l

0.05

4175

25085

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

213

147

14.04

226.80

2.1

3.2

—

(3028300) Cannabinoids [Presence] in Urine

979

3098

3.13

225.36

3.9

1.4

—

(3027008) Opiates [Presence] in Urine

977

3088

3.14

225.35

3.8

1.4

—

(3015736) pH of Urine

9523

69224

1.60

223.78

4.6

3.4

6.33

6.22

19.58

5279

38600

(3035350) Ketones [Presence] in Urine by Test strip

11530

87715

1.61

223.76

5.3

3.8

5.47

3.58

estimate

0.56

2752

17925

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

237

201

11.43

222.88

2.4

2.9

142.92

149.11

nmol/l

0.31

202

180

(3021601) Nitrite [Presence] in Urine by Test strip

11405

86621

1.60

222.13

5.2

3.8

0.00

estimate

0.35

2649

17370

(3009261) Glucose [Presence] in Urine by Test strip

11595

88558

1.60

219.25

5.3

3.8

0.44

0.43

estimate

0.01

2580

16962

(3022948) Iron [Moles/volume] in Serum or Plasma

4581

27759

1.75

217.30

2.6

2.7

12.25

12.94

umol/l

8.14

4221

25991

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

8193

57808

1.60

215.41

4.0

3.4

2.11

2.03

e6/l

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2320

11309

2.09

213.85

1.7

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3450

19301

1.86

213.15

2.1

1.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

7325

50418

1.62

212.73

3.3

3.1

1192.89

1468.30

ng/l

5.90

6230

43834

(3002582) Erythrocytes [#/volume] in Urine

7557

52575

1.60

208.89

4.0

3.3

71.96

89.87

e6/l

0.41

5941

39825

(3048689) Calprotectin [Mass/mass] in Stool

3377

18882

1.86

208.56

2.3

2.4

145.77

137.41

ug/g

0.42

2657

15074

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

293

370

7.69

204.69

2.1

1.6

110.95

105.14

umol/l

0.10

149

176

(3027944) Amphetamines [Presence] in Urine

939

3086

3.01

202.17

3.6

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3238

18046

1.86

201.37

2.2

1.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4277

25908

1.74

200.90

2.5

2.6

2.40

2.31

g/l

17.17

3889

24087

(3026782) Osmolality of Urine

4821

30203

1.70

200.20

3.4

3.0

495.27

528.29

mosm/kgh2o

19.97

4284

26556

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

156

20.10

198.30

2.0

2.3

16.17

19.64

umol/l

1.46

156

(3000850) Epithelial cells [#/volume] in Urine

5443

35620

1.64

189.09

3.1

2.7

6.70

5.59

e6/l

4.07

5014

32476

(3018095) Leukocytes [#/volume] in Urine

8310

60281

1.55

184.61

4.8

3.9

100.17

106.52

e6/l

0.25

6110

42075

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5003

32216

1.65

184.53

2.7

3.1

2.45

2.46

mmol/l

2.19

4426

28929

(3007164) IgA [Mass/volume] in Serum or Plasma

4759

30256

1.67

184.50

1.5

2.41

2.45

g/l

0.74

2776

18746

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

5387

35477

1.62

180.94

1.9

1.7

1.12

1.28

mg/l

3.62

4207

27977

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1994

9806

2.05

177.72

4.0

3.5

5.28

5.12

kpa

14.23

1911

9314

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3930

23979

1.71

176.88

2.6

2.7

20.59

22.51

14.48

3599

22400

(3020682) Albumin/Creatinine [Ratio] in Urine

7843

56579

1.54

176.17

4.3

4.1

8.21

7.94

mg/mmol

0.16

4872

34347

(3030467) Casts [#/volume] in Urine by Automated count

6523

45194

1.57

175.57

3.9

3.2

0.40

0.43

e6/l

0.72

4980

32837

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3546

21169

1.74

172.20

5.0

6.1

1.04

mmol/l

0.23

3296

19649

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

13196

106740

1.53

169.93

4.6

3.0

56.55

47.13

u/l

16.52

12328

100282

(3009343) pH of Capillary blood

1927

9506

2.04

169.93

4.0

3.5

7.41

7.42

3.03

1654

7821

(3012516) Albumin [Mass/volume] in Urine

7679

55599

1.52

166.93

3.6

3.5

41.34

43.96

mg/l

0.45

4876

34422

(3007853) Bacteria identified in Skin by Aerobe culture

3154

18369

1.77

166.51

2.0

1.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1718

8188

2.11

166.03

3.8

3.4

2.05

1.84

mmol/l

1.38

1333

5929

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2819

15997

1.80

162.20

4.2

3.8

5.91

5.79

kpa

8.27

2753

15644

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

17284

149627

1.74

161.13

7.3

5.1

1.82

1.96

mu/l

42.42

16115

138300

(3042936) Bacteria identified in Isolate by Culture

3712

22859

1.68

159.40

2.4

2.0

—

(3027801) Oxygen [Partial pressure] in Arterial blood

3182

18853

1.73

157.29

7.5

7.4

11.53

12.73

kpa

38.23

3055

18132

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3183

18861

1.73

157.28

7.5

7.4

5.23

5.06

kpa

17.64

3066

18148

(3019977) pH of Arterial blood

3183

18867

1.73

157.08

7.6

7.4

7.41

7.42

4.15

1878

10107

(36304419) Bacteria [Presence] in Urine

6137

42773

1.54

156.71

3.8

3.1

40.24

117.00

estimate

0.48

208

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1106

4509

2.43

155.30

1.5

1.4

280.57

271.80

ug/g

0.46

624

2699

(3002032) Base excess in Venous blood by calculation

2728

15568

1.79

153.33

4.3

3.8

2.16

1.79

mmol/l

5.56

2440

13687

(3003396) Base excess in Arterial blood by calculation

3146

18713

1.73

152.92

7.5

7.4

1.38

0.87

mmol/l

9.70

2639

15433

(3042517) Benzodiazepines panel - Urine

48.71

151.50

2.2

1.3

—

(3012544) pH of Venous blood

2808

16249

1.76

150.23

4.2

3.8

7.38

0.39

1674

9445

(3029937) Albumin [Presence] in Urine by Test strip

6672

47742

1.51

148.73

5.4

4.0

0.00

estimate

6.42

2494

15933

(3024354) Oxygen [Partial pressure] in Venous blood

2398

13282

1.83

148.51

3.8

3.1

4.62

4.50

kpa

1.60

2332

12963

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4652

30815

1.58

147.19

1.4

1.3

33.58

37.31

iu/ml

0.70

1322

9979

(3037522) Nuclear Ab [Titer] in Serum

3632

22750

1.65

144.36

1.4

443.96

564.09

titre

4.25

758

5146

(3016502) Oxygen saturation in Arterial blood

2851

16760

1.74

143.77

7.6

7.8

95.03

95.76

7.79

2771

16167

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4310

28453

1.58

136.86

1.4

1.3

10.21

13.60

u/ml

2.48

1589

11349

(3021589) Normoblasts [#/volume] in Blood

9400

72844

1.44

135.35

14.3

11.2

0.00

e9/l

0.51

7793

59504

(3014111) Lactate [Moles/volume] in Serum or Plasma

2469

14281

1.75

130.92

7.5

1.39

1.32

mmol/l

1.95

2426

14007

(3000494) Fungus identified in Specimen by Culture

3137

19384

1.65

130.09

1.6

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

774

2898

2.62

129.69

2.7

2.6

32.58

33.94

umol/l

0.98

705

2608

(3027945) Reticulocytes/Erythrocytes in Blood

3035

18746

1.65

125.65

2.4

2.5

1.85

1.78

3.94

2660

16796

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2598

15430

1.71

124.81

2.2

2.3

0.21

g/l

1.04

2407

14527

(3013512) EKG study

7726

58340

1.44

124.51

4.4

3.6

0.81

0.75

0.23

167

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

8544

65820

1.42

122.69

5.4

3.8

2.19

0.82

estimate

1.28

2183

14017

(3020191) Ethanol [Moles/volume] in Serum or Plasma

340

800

4.13

121.89

1.9

1.2

1.31

1.07

promille

2.07

268

651

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2508

14934

1.70

118.91

3.0

2.4

34.26

52.72

u/l

1.73

2065

12686

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1150

5391

2.11

114.79

2.0

2.2

532.24

621.67

ug/l

0.44

1080

5088

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1131

5306

2.11

112.62

3.1

2.8

25.36

24.66

mmol/l

6.70

1112

5210

(3019150) Specific gravity of Urine by Refractometry

5284

37787

1.46

110.75

5.5

4.0

1.02

1.10

kg/l

0.79

3669

24957

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1776

9850

1.80

107.58

2.9

3.6

4.31

4.49

pmol/l

12.36

1543

8941

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2570

15798

1.64

106.97

8.3

8.2

120.52

120.32

g/l

0.19

2519

15429

(3021387) Prolactin [Units/volume] in Serum or Plasma

807

3373

2.35

106.56

1.7

1.8

360.45

278.88

mu/l

4.97

708

3114

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1492

7876

1.88

105.91

1.6

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

5493

39913

1.44

104.58

4.8

3.7

0.27

0.26

0.02

474

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2163

12783

1.70

104.58

3.8

3.9

1.23

mmol/l

0.87

1874

11117

(3017732) Neutrophils [#/volume] in Blood

3216

20961

1.56

104.48

3.8

3.1

4.71

4.44

e9/l

0.87

2725

18125

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1693

9338

1.81

104.32

2.0

1.7

—

(3022145) Colonoscopy Study observation

2955

18903

1.58

104.12

1.3

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

2393

14552

1.65

103.70

2.3

2.7

71.55

68.74

e9/l

3.35

1801

10802

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

2073

12195

1.70

101.79

1.5

—

(3002179) Metamyelocytes/Leukocytes in Blood

2327

14118

1.66

101.61

4.6

4.4

0.65

0.76

1.25

721

4351

(3017181) Myelocytes/Leukocytes in Blood

2422

14874

1.64

100.75

4.8

4.5

0.88

0.96

0.68

752

4546

(40758558) Short blood count panel - Blood

6602

49891

1.40

99.55

7.6

6.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2917

18796

1.57

99.16

2.7

6.87

9.11

umol/l

8.89

2434

16671

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

9645

77714

1.36

97.13

3.1

2.7

—

estimate

—

(3044640) Blood type and Crossmatch panel - Blood

7008

53666

1.39

96.94

2.7

2.4

—

(3021440) Promyelocytes/Leukocytes in Blood

2313

14228

1.63

95.22

4.9

4.6

0.12

650

3920

(3025159) Blasts/Leukocytes in Blood

2327

14371

1.62

94.20

5.2

4.7

0.06

0.44

5.95

609

3818

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4446

31591

1.45

93.60

4.6

3.8

218.41

472.88

ng/l

5.08

3404

25055

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

972

4625

2.07

92.89

1.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1500

8253

1.80

92.78

4.6

3.9

49.31

46.61

4.03

1484

8147

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1582

8860

1.77

92.13

4.2

4.0

24.59

24.19

mmol/l

5.01

1558

8760

(3000991) Gas panel - Venous blood

2244

13813

1.63

91.91

8.9

8.8

—

(21494755) Public health laboratory ask at order entry panel

761

14920

0.47

91.73

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1039

5088

2.01

91.72

4.2

3.8

24.98

24.88

mmol/l

0.51

975

4625

(36660697) Celiac disease serology panel - Serum

2002

12081

1.65

88.54

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4064

28663

1.45

88.23

3.5

2.9

1.86

1.13

e6/l

0.53

2282

15266

(3033658) Prothrombin time (PT) actual/Normal

5578

41723

1.39

86.54

4.8

4.0

92.77

89.75

16.53

5423

40873

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1186

6194

1.89

86.53

1.3

1.2

0.55

0.98

u/ml

1.20

117

516

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1717

10020

1.70

86.13

7.1

6.5

25.07

24.44

mmol/l

9.57

1658

9578

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1503

8466

1.76

85.58

3.6

2.7

1.39

1.17

11.73

1491

8423

(3045414) Leukocytes [Presence] in Urine

2505

16091

1.56

85.25

2.3

2.1

0.01

0.02

estimate

1.76

502

3182

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1034

17902

0.53

84.87

2.0

3.50

3.44

ratio

0.99

805

14040

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3564

24728

1.46

83.75

1.9

2.1

29.45

29.61

0.79

3450

24071

(3003181) Sodium [Moles/volume] in Urine

662

2818

2.30

83.63

1.5

1.3

57.21

61.15

mmol/l

1.77

513

2277

(3004119) Hemoglobin [Mass/volume] in Venous blood

1724

10171

1.68

82.90

3.9

3.2

127.94

128.23

g/l

0.22

1662

9908

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

926

4512

2.01

82.76

1.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1484

8410

1.75

82.62

3.6

2.7

0.64

0.62

0.70

1474

8380

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2106

13080

1.61

82.61

3.4

4.0

86.00

91.43

ng/l

1.81

1775

11287

(3025941) Bacteria identified in Stool by Culture

1414

7928

1.76

81.69

1.3

1.2

—

(3020891) Body temperature

1342

7471

1.77

79.38

4.9

4.2

36.93

36.89

°c

4.63

1328

7412

(3020779) Urea [Moles/volume] in Serum or Plasma

2273

14503

1.57

79.27

5.9

7.6

9.55

10.40

mmol/l

6.54

2143

13845

(3028626) Oxygen [Partial pressure] in Capillary blood

763

3528

2.12

78.52

3.1

2.9

7.98

8.11

kpa

1.45

747

3433

(3017143) Hepatitis C virus Ab [Presence] in Serum

2452

15945

1.54

78.49

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3210

22106

1.47

77.75

1.8

1.7

—

(3044889) 12 lead EKG panel

13374

115183

1.33

76.74

4.8

4.0

0.50

2539.43

0.99

261

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

17781

160557

1.51

76.58

23.6

15.1

23.23

24.66

mg/l

7.35

15679

131018

(3019225) pH of Specimen

2410

15697

1.54

76.44

4.4

4.3

7.36

0.05

1774

11109

(3005719) IgG [Mass/volume] in Serum or Plasma

1982

12366

1.60

75.92

2.7

3.1

10.16

10.67

g/l

6.09

1802

11525

(3026493) Urate [Moles/volume] in Serum or Plasma

5776

44317

1.35

73.76

2.7

336.71

340.06

umol/l

1.55

4949

39295

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2426

16003

1.52

72.23

4.4

3.2

—

(3008295) Osmolality of Serum or Plasma

410

1498

2.66

72.01

1.4

276.47

277.54

mosm/kgh2o

0.36

322

1155

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1565

9330

1.66

71.88

2.0

1.7

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

726

3408

2.08

71.74

1.3

515.27

579.33

mg/l

1.06

686

3292

(3027273) Bicarbonate [Moles/volume] in Venous blood

1312

7488

1.73

70.89

4.1

3.3

25.60

25.24

mmol/l

2.99

1279

7261

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1594

9585

1.65

70.75

9.0

9.4

24.58

24.25

mmol/l

3.65

1545

9380

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3645

26106

1.41

70.57

3.6

3.0

3.33

3.00

e6/l

0.83

1841

12682

(3019550) Sodium [Moles/volume] in Serum or Plasma

18177

165368

1.53

70.30

27.3

17.8

139.43

139.77

mmol/l

55.78

17910

162013

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1319

7564

1.72

70.03

5.3

4.7

1.68

1.57

2.53

1264

7186

(3021901) Oxygen saturation in Capillary blood

675

3119

2.11

69.53

3.1

2.9

89.91

90.00

0.15

661

3019

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

661

3043

2.12

68.75

1.3

1.2

3.89

3.74

mmol/l

2.66

619

2894

(3041096) Erythrocytes [Presence] in Urine by Automated

5983

46548

1.33

68.35

4.7

3.3

0.65

0.31

estimate

0.70

2198

13594

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

5302

40567

1.34

67.75

2.7

2.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

18193

165746

1.52

67.59

27.5

18.0

3.97

mmol/l

1.15

17917

162122

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1690

10425

1.61

67.51

2.0

1.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

17078

153754

1.42

67.14

8.4

6.2

40.35

39.32

mmol/mol

39.66

15926

143804

(3018405) Lactate [Moles/volume] in Arterial blood

955

5055

1.85

66.49

3.9

1.41

1.38

mmol/l

0.29

946

4954

(3009214) Lutropin [Units/volume] in Serum or Plasma

651

3030

2.10

65.78

1.4

1.3

11.51

12.69

u/l

1.05

507

2501

(3020630) Protein [Mass/volume] in Serum or Plasma

2146

14072

1.52

65.27

2.4

2.8

66.11

66.28

g/l

0.51

1946

12903

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

736

13061

0.52

64.38

1.8

1.7

3.47

3.53

mmol/l

0.70

516

9081

(3026389) Candida sp identified in Specimen by Organism specific culture

523

2252

2.26

64.26

1.5

1.4

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1708

10682

1.58

64.24

9.2

9.3

1.45

1.29

7.41

1699

10616

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

63.59

1.6

0.0

483.61

—

nmol/l

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1659

10337

1.59

63.36

9.4

9.6

0.65

0.64

0.37

1652

10283

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

641

3012

2.08

63.14

1.4

1414.37

2139.32

e6/l

0.40

502

2372

(3003327) Ova and parasites identified in Stool by Light microscopy

954

5133

1.82

62.95

1.7

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

318

1093

2.82

62.86

1.8

1.9

395.12

332.86

mu/l

1.36

264

878

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

275

873

3.05

62.70

1.6

2.2

17.09

16.65

nmol/l

0.39

259

828

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

631

2962

2.08

62.32

1.4

12.20

38.95

e6/l

3.67

464

2191

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2031

13295

1.52

62.10

2.6

2.3

5.60

7.45

ug/l

3.29

1679

11760

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1281

7554

1.67

61.06

1.1

1.13

10.10

u/ml

1.10

(3028026) IgM [Mass/volume] in Serum or Plasma

1551

9635

1.59

59.87

1.8

2.0

1.24

1.33

g/l

1.33

1416

8875

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1138

6539

1.71

59.76

2.1

1.9

2.40

2.48

ug/l

0.07

988

5833

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2699

18854

1.43

59.01

8.9

6.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

757

3864

1.91

58.91

1.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1633

10331

1.56

58.19

8.1

7.9

25.22

24.72

mmol/l

6.22

1615

10268

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

749

3835

1.91

57.74

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

755

3876

1.90

57.74

1.2

—

(4024509) Urine culture

1275

7627

1.64

57.39

2.3

1.9

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1176

6904

1.67

56.93

5.6

4.9

0.84

0.88

2.81

1125

6537

(1616796) Gas panel - Central venous blood

659

3283

1.96

55.11

4.2

3.5

—

(3010421) pH of Blood

887

4860

1.79

55.01

4.3

3.3

7.41

1.50

871

4806

(3014051) Protein [Presence] in Urine by Test strip

5939

47248

1.29

54.70

3.8

2.9

0.07

190

1253

(3006184) Hemoglobin [Mass/volume] in Capillary blood

733

3797

1.88

54.51

2.4

2.2

128.82

128.73

g/l

0.03

571

2864

(3005322) IgE [Units/volume] in Serum or Plasma

1590

10141

1.55

54.50

1.4

1.3

204.77

220.51

u/ml

0.24

1478

9443

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2029

13669

1.47

53.42

2.7

2.4

0.46

0.41

e6/l

0.39

1955

13037

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2730

19498

1.40

52.03

3.3

4.8

235.24

248.10

u/l

4.49

2545

18567

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

594

2921

1.98

51.57

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

594

2921

1.98

51.57

1.4

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1374

8588

1.57

51.41

2.5

2.4

—

(3006653) Thiamine [Moles/volume] in Blood

201

598

3.25

51.19

1.3

1.2

141.06

134.60

nmol/l

0.91

201

598

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

647

3296

1.91

50.63

1.8

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

875

4927

1.74

49.30

1.6

1.7

0.24

0.23

g/l

1.41

826

4690

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

7.43

48.63

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

892

5078

1.72

48.31

1.6

1.7

1.23

1.18

g/l

4.47

845

4862

(40767503) Oxygen content in Capillary blood by calculation

614

3130

1.91

47.95

3.1

2.5

16.19

16.33

0.55

604

3056

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

197

615

3.09

46.35

1.7

1.3

1564628.38

1794294.25

iu/ml

0.06

(3008402) Methanol [Moles/volume] in Serum or Plasma

7.49

46.27

1.1

—

mmol/l

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1079

6533

1.62

46.05

1.4

1.3

30.04

34.47

iu/l

3.96

893

5762

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

17174

156683

1.34

45.74

6.5

5.0

6.14

5.91

mmol/l

77.36

15788

144453

(40761536) Microorganisms panel - Urine sediment

1788

12095

1.46

45.72

5.4

3.9

—

(3045424) Erythrocytes [Presence] in Urine

1292

8181

1.55

45.50

2.2

2.1

0.01

0.15

estimate

0.80

399

2511

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1019

6127

1.63

44.72

2.2

2.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2776

20389

1.35

43.81

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

330

1381

2.31

43.46

1.6

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

1113

6897

1.58

43.05

1.7

1.8

7.46

7.31

iu/ml

0.05

257

1626

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

232

826

2.71

43.03

1.9

1.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

468

2261

2.01

42.75

2.1

1.7

1.68

1.72

mmol/l

0.34

457

2193

(3025468) Yersinia sp identified in Specimen by Organism specific culture

412

1900

2.10

42.70

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

413

1910

2.10

42.49

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1575

10550

1.47

42.25

1.2

99.18

153.05

u/ml

6.97

551

4143

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

960

5770

1.63

42.17

2.7

2.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1172

7387

1.55

42.06

1.1

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

411

1908

2.09

41.87

1.4

—

(3045716) Anion gap in Serum or Plasma by calculation

374

1676

2.16

41.75

3.0

3.1

10.02

10.79

mmol/l

3.66

369

1659

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1864

12926

1.42

41.49

3.1

2.9

155.18

217.79

ng/l

8.93

1684

11910

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

716

4014

1.74

40.94

1.5

1.6

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

354

1565

2.19

40.89

1.3

1.2

34.00

35.80

nmol/l

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

418

1971

2.06

40.84

1.4

—

(3012501) Base excess in Blood by calculation

579

3051

1.84

40.80

4.9

3.6

2.66

2.53

mmol/l

0.46

413

2090

(3013290) Carbon dioxide [Partial pressure] in Blood

579

3052

1.84

40.76

4.9

3.6

5.09

4.96

kpa

3.29

562

2992

(3027315) Oxygen [Partial pressure] in Blood

582

3074

1.84

40.70

4.9

3.6

8.33

8.62

kpa

3.54

565

3014

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

426

2026

2.04

40.67

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

730

4127

1.72

40.51

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

929

5601

1.62

40.28

2.1

1.8

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

848

5001

1.65

40.15

1.3

32.40

44.29

u/ml

0.54

266

(3024522) Salmonella sp identified in Specimen by Organism specific culture

418

1984

2.04

40.13

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1190

7604

1.53

40.09

1.5

1.8

1.65

1.55

g/l

3.03

1016

6495

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1112

7027

1.55

39.40

1.3

1.7

16.08

17.57

iu/ml

—

210

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

262

5572

0.44

38.41

1.1

0.55

0.62

ratio

1.59

789

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1418

9498

1.46

37.91

10.0

9.5

15.93

15.98

0.27

1373

9158

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1618

11129

1.43

37.53

2.5

2.4

20.58

22.73

au/ml

0.41

108

1257

(3040151) Glucose [Moles/volume] in Capillary blood

364

1685

2.09

37.40

5.0

5.9

7.69

7.44

mmol/l

0.26

295

1383

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

394

1880

2.03

37.30

1.4

1.3

31.50

36.08

u/l

1.68

305

1545

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

503

2613

1.87

37.10

2.2

1.7

188.21

202.26

pmol/l

2.34

466

2497

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

561

3026

1.80

36.65

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1494

10191

1.44

36.22

1.3

45.04

56.38

au/ml

1.32

702

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

639

3603

1.72

35.80

1.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

425

2120

1.94

35.48

7.0

6.0

11.83

11.96

mg/l

0.24

393

1947

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

789

4716

1.63

35.40

1.3

8.88

5.62

u/ml

0.46

458

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

789

4720

1.63

35.28

1.3

4.53

6.40

u/ml

1.15

109

706

(3000475) Leukocytes [#/volume] in Synovial fluid

729

4290

1.65

34.80

1.7

12180.84

13117.89

e6/l

0.25

533

3069

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

639

3632

1.71

34.78

1.3

1.2

45.47

47.18

u/ml

0.08

358

(3017569) Oxygen content in Arterial blood

215

825

2.52

34.39

2.2

2.0

15.61

15.86

0.55

215

825

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

951

5991

1.55

34.12

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

462

2412

1.86

33.58

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1086

7063

1.50

33.57

1.9

2.1

39.27

40.04

u/l

0.63

966

6267

(3003129) Base excess in Capillary blood by calculation

378

1854

1.97

33.17

2.6

2.3

1.25

0.44

mmol/l

3.61

368

1787

(3024928) Oxygen saturation in Venous blood

668

3897

1.67

32.98

3.6

3.1

61.93

62.13

0.08

628

3793

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

323

1500

2.08

32.96

1.3

1.60

1.41

nmol/l

2.06

291

1354

(3034770) Mitochondria Ab [Titer] in Serum

750

4524

1.61

32.43

1.2

585.45

1107.03

titre

1.80

175

(3023419) Bacteria identified in Sputum by Culture

404

2047

1.91

32.22

2.8

2.6

—

(3008037) Lactate [Moles/volume] in Venous blood

711

4244

1.63

32.08

3.9

3.0

1.56

1.55

mmol/l

0.11

699

4149

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

606

3475

1.69

31.94

2.1

1.7

41.24

43.17

nmol/l

1.05

594

3384

(3022806) Fractional oxyhemoglobin in Capillary blood

356

1733

1.99

31.93

2.0

1.7

88.61

89.83

3.08

350

1708

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

769

4686

1.60

31.87

2.4

2.5

0.00

g/l

0.07

670

4111

(3044242) Glucose [Moles/volume] in Arterial blood

208

816

2.46

31.78

2.2

1.9

8.30

8.17

mmol/l

0.17

208

816

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

752

4563

1.60

31.73

1.9

1.6

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

161

557

2.79

31.68

1.8

1.6

2.18

1.95

umol/l

2.69

145

511

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

679

4020

1.64

31.66

1.2

1.3

4.59

6.18

u/ml

0.24

300

(3007566) Smooth muscle Ab [Titer] in Serum

748

4538

1.60

31.58

1.2

110.56

150.17

titre

0.88

422

(3047181) Lactate [Moles/volume] in Blood

780

4783

1.59

31.48

6.5

5.5

1.33

1.29

mmol/l

0.49

692

4234

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

703

4205

1.63

31.46

1.3

15.16

10.24

u/ml

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

211

840

2.42

31.24

1.0

260.74

403.19

ng/l

2.64

151

632

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

918

5855

1.53

31.11

2.4

2.6

0.63

0.88

g/l

2.02

796

5015

(3020961) Endomysium IgA Ab [Titer] in Serum

1060

6967

1.48

31.08

1.1

173.82

215.66

titre

0.22

206

(3016650) Hepatitis A virus Ab [Presence] in Serum

457

2439

1.82

30.97

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

211

844

2.41

30.92

1.0

33.78

43.28

ng/l

3.53

145

624

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

731

4433

1.60

30.92

1.3

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

210

841

2.41

30.70

1.0

883.12

736.81

ng/l

3.27

143

612

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

746

4562

1.59

30.46

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1046

6894

1.48

30.24

2.3

2.5

4.28

4.23

g/l

1.15

956

6284

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

498

2746

1.76

30.24

1.6

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

542

3061

1.72

30.23

1.5

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

725

4412

1.60

30.22

3.3

3.2

1.73

2.23

index

1.14

375

2195

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1046

6904

1.48

30.02

2.3

2.5

7.50

7.38

g/l

1.52

954

6288

(3022621) pH of Urine by Test strip

1838

13385

1.35

29.94

3.2

2.6

6.13

6.05

3.46

1243

9015

(3024980) IgG subclass 4 [Mass/volume] in Serum

495

2735

1.75

29.85

1.5

1.6

0.64

0.80

g/l

3.22

375

2143

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1042

6883

1.48

29.79

2.3

2.5

3.66

3.70

g/l

0.40

951

6273

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

910

5867

1.51

29.30

2.0

1.8

—

(3000330) Specific gravity of Urine by Test strip

1260

8666

1.42

29.04

4.4

3.4

1.02

ratio

0.35

1150

7844

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

229

977

2.26

28.99

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

985

6474

1.48

28.87

2.3

2.5

2.92

2.89

g/l

0.44

894

5858

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

785

4921

1.55

28.78

2.4

2.5

0.02

0.03

g/l

0.11

712

4428

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

715

4395

1.58

28.57

2.4

2.5

0.00

g/l

-0.00

668

4104

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

908

5893

1.50

28.32

2.2

2.4

9.69

10.27

g/l

3.92

810

5218

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

535

3071

1.69

28.13

1.8

0.92

0.84

nmol/l

1.81

452

2618

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

225

966

2.25

28.07

1.2

—

(3016038) Potassium [Moles/volume] in Urine

231

1004

2.22

27.98

1.3

1.1

28.29

35.44

mmol/l

5.84

185

892

(3011985) Renin [Units/volume] in Plasma

435

2372

1.78

27.48

1.4

1.5

70.49

54.31

mu/l

0.61

390

2141

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3214

25457

1.25

27.39

1.6

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

511

2923

1.69

27.23

1.2

1.3

—

26.63

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

196

806

2.35

27.07

1.4

1.2

212.65

387.29

u/l

1.94

175

750

(3016244) Insulin [Units/volume] in Serum or Plasma

171

661

2.49

27.05

2.9

3.1

22.98

25.35

mu/l

0.41

162

626

(3020911) Cortisol [Moles/time] in 24 hour Urine

141

496

2.74

26.96

1.5

1.4

95.79

216.30

nmol/24h

1.48

141

496

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

206

871

2.28

26.68

1.4

4.86

5.87

u/l

3.05

177

750

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

16961

156588

1.24

26.54

21.4

15.1

79.39

78.91

ml/min/173m2

2.43

16058

144665

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

603

3634

1.61

26.20

2.2

2.4

96.43

101.85

ug/min

0.10

329

2146

(3034860) Kappa light chains.free [Mass/volume] in Serum

891

5852

1.48

26.20

2.9

3.6

104.29

66.88

mg/l

0.26

752

5012

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

889

5843

1.48

26.05

2.9

3.6

37.40

48.76

mg/l

2.37

750

5006

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

372

1973

1.82

25.80

2.2

2.0

24.34

25.74

mg/l

0.21

136

714

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

283

1372

1.99

25.78

1.6

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

748

4754

1.53

25.77

1.8

1.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

433

2406

1.74

25.65

1.3

0.14

0.23

nmol/l

2.51

144

(3024139) IgG subclass 3 [Mass/volume] in Serum

325

1662

1.89

25.31

1.5

1.4

0.36

0.44

g/l

3.65

229

1207

(3027135) IgG subclass 1 [Mass/volume] in Serum

325

1664

1.89

25.22

1.5

1.4

6.16

6.90

g/l

4.01

227

1210

(3028192) IgG subclass 2 [Mass/volume] in Serum

325

1664

1.89

25.22

1.5

1.4

2.69

2.96

g/l

2.37

229

1210

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

423

2348

1.74

25.16

1.3

1.64

2.39

nmol/l

0.23

411

2268

(3044941) Cell count panel - Synovial fluid

513

3004

1.65

25.03

1.6

1.4

—

(4062490) Immunoglobulin typing, IgG

318

1623

1.89

24.92

1.5

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

225

1015

2.14

24.90

1.3

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

897

5960

1.46

24.87

1.6

15.70

19.66

u/ml

0.82

140

1459

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

131

463

2.73

24.87

2.6

3.3

28.08

28.48

umol/l

0.13

366

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

445

2516

1.71

24.79

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

172

698

2.38

24.53

1.7

1.6

2.68

7.85

nmol/l

0.88

133

595

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

132

472

2.69

24.51

1.3

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

400

2202

1.76

24.50

1.3

313.66

352.03

pmol/l

0.34

331

1892

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

222

1004

2.13

24.42

1.3

1.4

—

(3023410) Appearance of Cerebral spinal fluid

275

1348

1.97

24.31

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

708

4513

1.52

24.07

2.0

2.2

12.20

11.58

mg/l

0.79

662

4205

(3006571) Granulocytes/Leukocytes in Synovial fluid

377

2056

1.77

23.87

1.7

1.6

55.67

57.29

0.30

233

1312

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

236

1103

2.06

23.82

1.5

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

553

3347

1.60

23.64

1.3

1.2

—

(3008898) HLA-B27 [Presence]

748

4849

1.50

23.47

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

155

613

2.44

23.42

2.6

2.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1540

11319

1.33

23.36

1.2

1.3

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

414

2334

1.72

23.33

1.2

3.67

11.45

u/ml

1.95

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

235

1107

2.05

23.24

1.3

1.2

2.08

2.20

mmol/l

0.83

217

1032

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

133

492

2.60

23.12

1.5

14.52

16.10

pmol/l

2.19

102

425

(3020717) Zinc [Moles/volume] in Serum or Plasma

185

803

2.22

22.59

1.5

1.4

18.02

24.81

umol/l

3.04

170

745

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

256

1257

1.97

22.56

1.4

1.6

21.67

25.51

u/ml

0.61

231

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

722

4692

1.49

22.39

1.4

1.5

24.23

14.23

iu/ml

0.65

109

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

371

2063

1.74

21.99

1.3

0.19

0.20

nmol/l

0.64

291

1652

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

786

5222

1.46

21.81

2.9

3.5

2.33

7.06

ratio

1.33

452

3083

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

358

1976

1.75

21.78

1.3

—

nmol/l

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

244

1193

1.97

21.78

1.3

1.1

—

(3039000) Anion gap in Blood by calculation

539

3313

1.58

21.61

7.6

6.5

10.89

11.22

mmol/l

1.45

494

2977

(3018572) Chloride [Moles/volume] in Blood

539

3314

1.58

21.58

7.6

6.5

104.67

105.13

mmol/l

1.26

494

2979

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

270

1373

1.90

21.47

1.1

—

69.27

—

(3042631) Mycobacterium sp identified in Specimen

376

2115

1.72

21.40

2.9

2.7

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

223

1063

2.02

21.39

1.2

1.3

20.00

60.55

titre

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

227

1095

2.00

21.07

1.3

916.92

487.09

titre

0.37

(3014271) Vancomycin [Susceptibility]

158

664

2.29

20.88

3.2

2.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

302

1609

1.81

20.74

1.5

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

978

6828

1.39

20.61

1.3

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

189

859

2.12

20.61

1.1

2.83

9.49

nmol/l

1.83

178

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

352

1967

1.73

20.53

1.6

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1477

10989

1.31

20.49

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

521

3223

1.57

20.34

2.4

2.1

3656.49

4714.39

u/l

0.45

175

1340

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

239

1190

1.94

20.28

1.6

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

598

3817

1.52

20.25

1.1

1.97

9.44

eliau/ml

8.08

464

(3000492) Spirometry study

1992

15430

1.26

20.14

1.6

1.5

—

17.22

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

285

1507

1.83

20.08

1.6

31.35

30.85

0.07

158

931

(3017509) Phencyclidine [Presence] in Urine

5.11

20.07

2.6

1.1

—

(3037121) Protein [Mass/volume] in Urine

813

5548

1.42

19.55

2.9

3.3

842.78

507.71

mg/l

0.53

276

2443

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

236

1188

1.92

19.40

1.3

1.4

0.83

1.54

u/ml

0.92

149

676

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

274

2.98

19.21

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

439

2648

1.60

19.11

1.4

1.5

24.79

12.34

u/ml

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

257

1341

1.85

18.93

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

257

1341

1.85

18.93

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

257

1341

1.85

18.93

1.4

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1379

10302

1.30

18.53

2.9

2.1

12.43

13.03

nmol/l

2.01

1196

9385

(3004809) Band form neutrophils/Leukocytes in Blood

455

2790

1.58

18.50

3.2

3.7

1.54

1.65

0.27

398

2518

(3036180) Methadone [Presence] in Urine

+∞

18.45

1.3

0.0

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

282

2.90

18.28

1.2

1.6

74.96

72.87

1.05

271

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

487

3042

1.55

18.25

1.2

1.3

120.48

323.63

titre

4.95

241

(40757494) Bilirubin.total [Moles/volume] in Blood

162

728

2.14

18.25

2.0

2.2

15.15

30.62

umol/l

1.01

(3038515) Glucose [Moles/volume] in Venous blood

562

3622

1.50

18.21

4.2

3.2

7.67

7.50

mmol/l

0.65

552

3546

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

162

729

2.14

18.19

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

162

729

2.14

18.19

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

488

3053

1.55

18.17

1.2

1.3

165.71

151.69

titre

—

(40768443) Skin Pathology biopsy report

1086

7868

1.34

18.12

1.3

1.2

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

145

625

2.23

18.12

1.2

1.3

63.36

60.57

0.11

(3010838) Calcium [Moles/time] in 24 hour Urine

512

3239

1.53

18.12

1.8

1.9

4.68

5.05

mmol/24h

1.80

450

2876

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

360

2103

1.65

17.86

1.9

1.7

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

130

541

2.31

17.66

1.6

1.2

3.07

4.00

umol/l

2.23

113

480

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

279

2.86

17.45

1.2

1.6

560.68

1006.91

mu/l

0.56

268

(1761482) Bacteria [#/volume] in Urine by Culture

637

4250

1.45

17.35

5.9

4.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

279

1538

1.75

17.17

3.8

—

(4146454) Self-monitoring of blood glucose

305

1727

1.70

17.05

2.5

2.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

131

558

2.26

16.88

1.1

1.2

—

(3000012) Reticulocyte production index

383

2313

1.60

16.66

1.7

2.2

0.85

0.88

0.45

258

1587

(3049717) Cytology report of Urine Cyto stain

833

5872

1.38

16.59

2.4

2.8

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

135

587

2.21

16.56

1.8

1.6

29.33

29.83

umol/l

0.22

129

550

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

273

1515

1.74

16.43

1.5

1.8

—

(3006270) Folate [Moles/volume] in Blood

224

1172

1.84

16.43

1.2

358.92

349.08

nmol/l

0.26

182

975

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

674

4601

1.42

16.23

1.8

1.9

3.32

14.33

iu/l

1.30

264

1869

(3004616) Nuclear Ab [Presence] in Serum

356

2126

1.62

16.23

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

236

1261

1.80

16.18

1.1

—

(3037756) Immunofixation for Serum or Plasma

545

3578

1.47

16.16

1.6

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2524

20501

1.21

16.14

5.6

5.0

31.54

32.96

7.78

1658

13522

(1002224) Polysomnography panel

923

6649

1.35

16.01

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

576

3830

1.46

16.00

1.5

1.6

—

(3004451) EKG impression Narrative

184

913

1.94

15.89

1.2

1.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

173

841

1.98

15.85

1.6

1.7

7.49

10.22

ug/l

1.28

161

773

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

113

468

2.32

15.58

4.2

2.6

5.19

4.91

kpa

2.01

113

468

(3034891) Synovial lining cells/cells in Synovial fluid

167

807

1.99

15.57

1.6

1.5

4.77

3.62

0.22

182

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

375

2.49

15.56

1.5

1.2

133.15

129.34

nmol/l

0.08

282

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

5.32

15.52

1.1

1.3

43.48

37.91

mg/l

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

113

469

2.32

15.51

4.2

2.6

9.72

10.66

kpa

3.11

113

469

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

322

1904

1.63

15.31

1.1

1.2

52.76

62.67

u/l

3.74

284

1659

(3039162) Centromere protein B Ab [Units/volume] in Serum

346

2084

1.60

15.26

1.2

1.3

73.43

62.60

u/ml

0.22

148

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7964

70791

1.13

15.23

2.1

1.9

1.52

1.31

mmol/l

51.56

6580

59505

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

275

1564

1.70

15.19

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

282

1619

1.68

15.04

3.3

3.9

—

(3019230) Fractional oxyhemoglobin in Venous blood

509

3353

1.47

14.87

3.8

2.8

60.87

62.38

0.83

504

3344

(4027681) Cerebrospinal fluid IgG ratio and IgG index

156

753

1.99

14.63

1.2

0.51

0.61

ratio

3.97

440

(3002079) Sodium [Moles/time] in 24 hour Urine

151

721

2.02

14.60

1.2

151.55

160.43

mmol/24h

0.64

151

721

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

331

2008

1.59

14.20

1.6

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

157

768

1.97

14.19

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

313

1874

1.61

14.19

1.5

1.4

0.32

0.37

nmol/l

0.57

223

1399

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

735

5216

1.36

14.08

1.6

1.5

0.45

10.55

iu/ml

1.49

142

1010

(3017354) Segmented neutrophils/Leukocytes in Blood

304

1811

1.62

14.07

3.2

3.7

57.23

57.84

0.20

255

1579

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

151

731

1.99

14.06

3.8

4.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

112

485

2.22

13.96

1.1

1.2

110.66

112.13

0.25

439

(40761511) CBC panel - Blood by Automated count

17683

165725

1.19

13.85

20.8

13.5

—

113.13

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

283

2.62

13.76

1.1

0.90

0.65

umol/24h

0.59

136

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

101

422

2.30

13.71

1.1

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

124

564

2.12

13.68

2.2

2.3

51.45

50.28

umol/l

0.14

110

487

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

254

1456

1.68

13.68

2.9

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

373

2354

1.53

13.47

1.1

567.87

1233.43

iu/ml

0.35

430

(3032057) Clostridioides difficile [Presence] in Stool

294

2.55

13.27

1.9

1.7

—

(3036489) Thrombin time

821

5982

1.33

13.23

1.8

2.0

20.96

21.19

0.32

705

5288

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

180

946

1.83

13.13

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

139

671

1.99

13.09

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

195

1057

1.78

12.85

1.2

1.1

33.32

44.86

mg/l

4.86

161

920

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

293

1782

1.59

12.50

1.2

43.63

44.52

u/ml

0.02

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

187

1010

1.78

12.49

1.6

1.4

—

(4015189) Microbial culture of sputum

379

2.31

12.49

3.1

2.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

236

2.69

12.49

2.0

1.9

122.45

54.27

pmol/l

0.55

199

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

581

4050

1.39

12.48

1.2

3.59

3.57

0.01

570

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

13637

135610

0.89

12.45

31.7

19.3

330.84

331.72

g/l

24.89

13560

134849

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

188

1019

1.78

12.41

1.1

253.77

277.22

mg/l

0.63

162

926

(43055514) Macroprolactin [Presence] in Serum or Plasma

210

2.79

12.41

1.3

1.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

141

698

1.94

12.38

1.8

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

174

923

1.82

12.35

1.6

1.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

114

524

2.09

12.29

1.1

1.2

0.31

0.30

g/l

0.74

428

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

168

883

1.83

12.28

1.6

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

321

2005

1.54

12.20

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

321

2005

1.54

12.20

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

321

2005

1.54

12.20

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

321

2005

1.54

12.20

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

237

3633

0.62

11.89

1.4

1.6

1030.14

1000.77

mu/l

0.12

190

2978

(3034274) Bile acid [Moles/volume] in Serum --fasting

212

1206

1.69

11.82

1.6

2.0

8.11

9.79

umol/l

0.41

144

897

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

142

717

1.91

11.79

1.0

1.1

1.12

1.13

u/l

0.06

294

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

422

2.19

11.62

1.2

24.12

25.84

0.07

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

229

1337

1.65

11.58

1.2

103.44

112.84

pmol/l

2.05

229

1337

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

251

1503

1.61

11.47

1.2

71.33

75.01

u/ml

0.06

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

211

1210

1.68

11.43

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

543

3800

1.38

11.42

1.2

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

294

1830

1.55

11.39

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

317

2009

1.52

11.31

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

185

1029

1.73

11.22

1.1

—

0.33

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

158

842

1.81

11.10

1.4

1.5

1.27

1.20

nmol/l

0.25

109

649

(3011412) CD3 cells [#/volume] in Blood

244

1469

1.60

10.93

1.9

2.3

1378.93

1193.26

e6/l

1.26

213

1322

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

415

2.15

10.88

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

231

1376

1.62

10.82

2.4

1.9

2.53

3.72

u/field

0.28

140

720

(3020564) Creatinine [Moles/volume] in Serum or Plasma

18313

172629

1.18

10.81

29.7

20.0

77.17

76.86

umol/l

0.56

18129

170543

(3044927) Protein electrophoresis panel - Urine

262

1610

1.57

10.77

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

331

2.29

10.76

1.2

328.06

302.91

pmol/l

0.17

243

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

235

1411

1.60

10.66

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

156

840

1.79

10.61

1.5

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

156

840

1.79

10.61

1.5

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

156

840

1.79

10.61

1.5

1.9

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

231

1383

1.61

10.61

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

121

601

1.94

10.60

1.6

2.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

156

841

1.79

10.57

1.5

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

120

595

1.94

10.57

1.6

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

120

595

1.94

10.57

1.6

2.2

—

(3011048) Pyruvate [Moles/volume] in Blood

4.70

10.53

1.5

1.2

75.84

70.73

umol/l

0.25

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

302

1927

1.51

10.48

3.2

3.5

4.42

11.90

nmol/l

1.14

290

1865

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

188

1073

1.69

10.42

1.2

1.3

30.17

25.68

u/l

0.37

158

893

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

192

1102

1.68

10.42

1.2

1.3

94.47

93.93

u/l

0.02

167

933

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

202

1175

1.66

10.42

3.0

3.7

111.88

174.69

nmol/l

1.42

195

1164

(40768800) Prostate Pathology biopsy report

189

2957

0.61

10.40

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

210

1239

1.63

10.25

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

321

2.28

10.19

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

117

3.20

10.13

1.9

1.8

53.28

48.07

umol/l

0.30

117

(3010144) Erythrocytes [#/volume] in Synovial fluid

255

1585

1.55

10.00

1.5

178302.20

110338.12

e6/l

0.68

179

1029

(3038026) Centromere Ab [Units/volume] in Serum

213

1270

1.62

9.98

1.2

48.93

51.56

u/ml

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

224

1355

1.59

9.89

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

224

1356

1.59

9.86

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

219

1319

1.60

9.85

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

510

3650

1.35

9.39

1.4

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

153

2434

0.60

9.08

1.4

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

196

1177

1.60

8.97

1.1

294.99

537.95

mg/l

0.49

179

1079

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

18138

171160

1.16

8.96

16.0

11.8

26.32

25.63

u/l

3.92

17671

166187

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2431

26275

0.87

8.82

3.1

3.2

0.64

0.79

ug/l

16.93

1614

17154

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

14384

133965

1.10

8.81

28.5

18.6

13.87

13.66

63.82

14236

132167

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

181

1071

1.63

8.81

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

132

722

1.76

8.61

1.2

1.1

5.38

3.86

iu/ml

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

308

2.18

8.58

1.8

1.3

0.13

0.38

mmol/l

3.12

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

170

998

1.64

8.55

1.9

2.4

572.22

548.57

e6/l

0.17

134

826

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

634

4745

1.29

8.53

2.5

3.83

3.59

g/l

3.32

601

4547

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

210

1301

1.55

8.44

1.2

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

180

2.56

8.40

1.0

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

148

845

1.69

8.30

2.2

1.7

2.23

2.71

u/field

0.41

105

571

(3024263) Appearance of Synovial fluid

145

824

1.69

8.28

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

129

2088

0.59

8.25

1.4

1.5

54.04

60.83

ug/l

1.34

1697

(3018333) Ribosomal P Ab [Presence] in Serum

205

1274

1.55

8.15

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

234

1502

1.50

8.01

1.1

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

319

2173

1.41

8.01

1.1

2.42

2.95

0.44

359

(37021550) Renin [Units/volume] in Plasma --upright

292

2.17

8.01

1.2

1.3

48.43

63.22

mu/l

0.67

213

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

714

5471

1.26

7.97

2.7

2.9

0.37

0.35

iu/ml

0.59

424

3015

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

215

2.37

7.88

1.0

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

345

2.06

7.86

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

7.77

7.82

1.1

—

mmol/l

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

254

1668

1.47

7.78

1.1

1.32

2.45

iu/ml

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

174

1055

1.59

7.73

1.5

7.50

6.76

u/l

0.25

134

838

(3001186) Copper [Moles/volume] in Serum or Plasma

355

2.03

7.66

1.3

1.2

16.22

16.73

umol/l

0.42

310

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

368

2589

1.37

7.65

1.2

1.1

24.27

14.17

au/ml

0.98

656

(3002619) Bacteria identified in Specimen by Culture

388

1.98

7.64

1.4

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

444

1.91

7.50

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

444

1.91

7.50

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

444

1.91

7.50

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

444

1.91

7.50

1.2

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

169

1026

1.58

7.48

1.1

77.12

87.23

u/l

1.07

146

913

(3020491) Glucose [Moles/volume] in Blood

172

1050

1.58

7.44

2.0

1.8

7.37

6.81

mmol/l

1.56

122

717

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

168

1020

1.58

7.44

1.1

19.52

26.94

u/l

1.26

144

908

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

119

2.82

7.43

1.5

1.3

10.85

19.76

pmol/l

0.97

104

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

125

704

1.71

7.43

2.3

2.1

159.90

152.05

0.43

119

659

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1636

13661

1.16

7.39

2.9

2.7

65.92

64.60

ml/min/173m2

0.68

726

5728

(3019832) Treponema pallidum Ab [Presence] in Serum

1170

9506

1.19

7.39

1.7

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

306

2101

1.40

7.39

1.9

31.63

23.59

ug/l

0.87

296

2056

(44813793) Dust mix specific IgE antibody measurement

179

1106

1.56

7.35

1.1

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.20

7.35

1.6

1.5

0.49

1.46

mg/l

0.77

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.20

7.35

1.6

1.5

1.19

1.74

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.20

7.35

1.6

1.5

1.42

1.36

mg/l

0.04

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.20

7.35

1.6

1.5

3.10

2.05

mg/l

0.27

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.20

7.35

1.6

1.5

3.59

4.22

mg/l

0.21

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.20

7.35

1.6

1.5

2.36

0.54

mg/l

0.53

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.20

7.35

1.6

1.5

2.10

1.30

mg/l

0.18

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.20

7.35

1.6

1.5

1.67

2.70

mg/l

0.53

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.20

7.35

1.6

1.5

3.22

1.84

mg/l

0.35

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

321

2225

1.39

7.33

1.1

1.52

g/l

0.09

294

2042

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

217

2.30

7.29

2.3

2.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

137

2.66

7.24

1.1

1.88

1.67

umol/24h

0.56

137

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.13

7.09

1.6

1.5

0.60

1.73

mg/l

1.50

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

475

1.84

7.02

1.7

0.40

0.38

ug/l

0.20

337

(3012494) Peanut IgE Ab [Units/volume] in Serum

315

2.04

7.01

1.0

1.1

0.47

1.21

u/ml

0.96

160

(21491868) Cryoglobulin [Mass/volume] in Serum

106

580

1.76

7.00

1.2

1.32

0.31

g/l

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

174

2.43

6.96

1.0

0.08

0.13

u/ml

0.22

120

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

222

2.25

6.93

2.2

1.9

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

124

2.71

6.91

1.3

1.2

0.16

0.35

nmol/l

1.61

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

151

911

1.59

6.90

1.2

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

467

1.83

6.77

1.1

1.2

115.30

108.25

0.82

429

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

168

1047

1.54

6.69

1.4

13.34

13.04

umol/l

0.18

157

992

(3010503) CD19 cells [#/volume] in Blood

156

957

1.57

6.66

2.2

2.5

507.17

391.47

e6/l

0.19

149

932

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

144

2.53

6.59

2.1

2.0

0.95

1.01

mmol/l

0.05

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

451

1.83

6.57

1.1

1.2

96.82

87.00

1.14

214

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

460

1.82

6.48

1.1

93.86

87.29

0.91

215

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

111

630

1.69

6.47

1.1

176.84

426.46

ng/l

0.81

190

(1175426) CD3 cells/Lymphocytes in Blood

183

1173

1.50

6.41

1.6

1.9

72.93

72.15

0.30

175

1134

(3012920) Ethanol [Mass/volume] in Serum or Plasma

11.73

6.40

1.3

1.0

2.18

2.15

g/l

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

540

4116

1.27

6.39

1.2

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

130

1965

0.63

6.36

1.3

1.5

1.18

1.15

ratio

0.15

1180

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

108

2.76

6.34

1.1

7.48

11.20

u/l

0.74

108

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

129

1951

0.63

6.33

1.3

1.4

—

(21494815) CD4 cells/Lymphocytes in Specimen

199

1304

1.47

6.27

1.9

2.1

42.69

38.14

3.89

194

1277

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

220

2.18

6.24

1.6

1.7

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

303

2.00

6.24

3.1

2.2

7.17

7.74

mmol/l

0.48

174

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

131

1967

0.64

6.23

1.3

1.5

1.35

1.17

ratio

0.87

1188

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

131

1967

0.64

6.23

1.3

1.5

0.97

0.96

ratio

0.15

1182

(3036670) Protein [Mass/volume] in Synovial fluid

494

1.77

6.23

1.3

40.89

40.40

g/l

0.11

258

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

166

1051

1.52

6.19

2.0

2.5

232.20

238.86

e6/l

0.17

139

918

(3013166) Neutrophils/Leukocytes in Synovial fluid

440

1.81

6.15

1.4

60.36

55.76

0.47

373

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

975

0.49

6.14

1.2

—

(4034850) Laboratory test

660

5170

1.23

6.14

14.2

9.5

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

139

848

1.58

6.12

1.6

2.0

102.18

98.27

0.57

132

801

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

204

2.21

6.07

1.4

130005.73

281072.72

nmol/l

0.38

169

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

630

4917

1.24

6.07

2.0

2.2

95.15

92.69

1.82

598

4735

(3043238) Trisomy 21 risk [Likelihood] in Fetus

109

1693

0.62

6.03

1.4

1.6

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

107

2.69

5.89

1.5

1.7

1.44

1.41

umol/l

0.15

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

308

2208

1.34

5.80

2.3

2.7

284.42

411.38

u/ml

0.24

303

2195

(3047352) Trisomy 18 risk [Likelihood] in Fetus

107

1652

0.62

5.79

1.3

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

305

2189

1.34

5.70

1.1

126.99

118.29

4.10

269

1979

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

174

1133

1.48

5.70

1.1

10.54

8.65

iu/ml

0.24

286

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

7.68

5.65

1.8

2.0

210.83

204.36

ug/l

0.06

(3020876) Protein [Mass/time] in 24 hour Urine

295

2111

1.35

5.63

2.1

2.5

1.30

1.15

g/24h

0.31

167

1256

(21494890) Protein electrophoresis panel - 24 hour Urine

251

1755

1.38

5.56

2.1

2.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

109

644

1.63

5.52

1.1

2.54

6.31

u/ml

1.70

(3005033) Fetal Nuchal fold Thickness US

107

1632

0.63

5.52

1.3

1.5

1.27

0.03

1166

(37208534) Antinuclear antibody arbitrary concentration in serum

499

1.71

5.50

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

584

4577

1.23

5.45

2.4

194.74

196.40

0.16

540

4347

(3024869) Neuronal Ab [Presence] in Serum

246

2.03

5.44

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

152

973

1.50

5.44

2.4

2.7

718.82

1173.10

u/ml

4.03

152

962

(3013336) Amino acids [Identifier] in Serum or Plasma

12.34

5.44

2.8

2.0

—

(3028433) Virus identified in Specimen by Culture

452

1.74

5.39

1.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

235

2.04

5.33

1.1

1.0

1.10

1.68

u/ml

0.18

197

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

646

5130

1.21

5.31

1.7

1.8

5.17

4.33

mg/l

0.83

550

3727

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

461

3532

1.26

5.30

3.9

5.9

539.12

1342.26

iu/ml

0.97

580

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

379

2839

1.29

5.24

1.2

1.3

26.06

33.45

u/l

1.12

321

2466

(3051651) Icteric interference index of Serum or Plasma

142

906

1.51

5.18

3.4

3.7

0.77

0.90

index

0.46

137

879

(4195642) Thrombophilia screening test

301

2190

1.32

5.17

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

309

2264

1.31

5.06

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

225

1572

1.38

5.05

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

349

1.82

5.01

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

263

1887

1.34

4.99

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.14

4.92

1.1

1.2

378.50

403.59

u/l

0.07

(3012565) Volume of 24 hour Urine

124

778

1.53

4.92

1.8

2.2

2128.64

1919.48

1.34

107

694

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

106

644

1.58

4.85

1.0

1.1

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

417

1.73

4.83

1.4

1.3

36.12

38.62

0.22

279

(3004775) Volume in Urine collected for unspecified duration

181

1229

1.42

4.83

2.0

2.3

658.80

665.97

0.08

121

848

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.71

4.82

1.2

1.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

202

2652

0.73

4.80

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

134

860

1.50

4.79

1.1

1.07

1.06

ratio

0.24

118

699

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.76

4.78

1.2

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

16278

153630

1.08

4.77

4.9

4.3

1.46

1.26

mmol/l

174.70

14828

141859

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

139

901

1.48

4.74

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

459

3566

1.24

4.71

5.2

3.2

24.66

27.38

mg/l

1.00

329

2509

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

316

2348

1.30

4.70

1.3

1.2

4.52

4.17

u/ml

0.22

141

1105

(3026470) Cobalt [Mass/volume] in Blood

152

1005

1.45

4.69

2.1

2.2

2.89

3.96

ug/l

1.54

138

931

(3035320) C reactive protein [Mass/volume] in Body fluid

181

1236

1.41

4.69

3.7

2.4

29.38

29.26

mg/l

0.01

134

899

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

148

975

1.46

4.66

1.9

1.8

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

101

613

1.58

4.66

1.0

1.1

103.50

96.73

1.33

490

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

302

1.84

4.65

1.2

1.3

1.17

1.18

mmol/l

0.23

302

(3006245) CD3-CD19+ cells/cells in Blood

547

1.62

4.62

1.4

2.0

10.79

10.05

0.23

499

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

106

652

1.56

4.62

1.1

56.89

7.40

u/ml

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

190

2.07

4.59

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

105

2.47

4.54

1.1

2.17

1.73

iu/ml

0.62

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.62

4.53

1.3

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

205

2658

0.74

4.52

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

166

2.14

4.50

1.7

1.4

0.53

0.49

e9/l

0.46

166

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

327

1.79

4.47

5.1

6.6

71.25

70.30

0.09

249

(3036603) Volume of Urine

191

1331

1.38

4.42

1.6

2203.18

1902.75

2.90

185

1297

(3025018) Bordetella pertussis Ab [Titer] in Serum

157

1058

1.43

4.41

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

301

1.82

4.40

1.2

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

187

2.05

4.39

2.7

2.3

0.60

0.58

u/field

0.04

187

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

189

1317

1.38

4.38

1.2

102.50

217.00

titre

1.49

210

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

181

2.07

4.37

1.6

1.2

45.25

56.33

0.64

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

358

1.74

4.36

1.2

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

137

904

1.46

4.31

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

347

2642

1.26

4.29

1.2

1.1

0.94

1.06

0.09

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

2.72

4.28

1.7

1.6

24.09

23.20

mmol/l

0.26

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

185

1294

1.37

4.21

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

191

2.01

4.17

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

355

2722

1.26

4.15

2.2

2.7

1582.86

6375.50

u/ml

0.77

171

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

485

3847

1.21

4.13

2.7

3.6

515.77

1028.94

u/ml

0.96

440

3491

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

504

1.60

4.11

2.0

1.8

8.77

9.35

mg/l

0.43

422

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.81

4.10

1.4

1.6

0.57

0.16

u/l

—

(3009015) Lactate [Moles/volume] in Synovial fluid

173

2.05

4.08

1.3

5.53

6.60

mmol/l

0.73

(3046861) Legionella sp Ag [Presence] in Urine

100

2.40

3.99

1.2

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

605

4916

1.19

3.99

2.6

2.9

1.54

1.60

mg/l

1.13

528

4477

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

326

1.74

3.95

1.2

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

137

2.17

3.95

1.0

1.1

0.04

u/ml

0.05

137

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2165

19121

1.10

3.88

3.1

4.4

31.62

27.24

ug/l

0.13

1770

15513

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

164

2.05

3.86

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

133

2.17

3.81

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

115

755

1.46

3.77

2.9

3.3

1.45

1.25

0.45

115

755

(3028717) Thiamine [Mass/volume] in Blood

179

1.98

3.75

1.2

62.62

62.55

ug/l

0.01

179

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

449

1.60

3.74

2.6

3.1

1.95

1.85

ratio

0.19

416

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

314

2406

1.26

3.74

1.3

1.2

3.63

3.93

u/ml

0.11

901

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

358

2785

1.24

3.73

1.2

1.3

263.61

280.46

u/ml

0.61

213

1796

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

17346

164458

1.08

3.71

6.7

5.8

2.59

2.75

mmol/l

100.95

16030

153504

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.90

3.67

1.0

172.88

157.15

pmol/l

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

122

817

1.43

3.62

1.1

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.78

3.62

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

328

1.70

3.61

1.3

1.2

0.82

62.53

mg/l

1.43

238

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

629

1.50

3.61

1.1

—

(3025577) Chromium [Mass/volume] in Blood

142

980

1.39

3.57

2.1

2.2

2.00

2.48

ug/l

1.44

120

821

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

204

1490

1.32

3.56

4.2

5.7

125.52

118.67

u/ml

0.04

521

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.46

3.55

1.2

1.1

0.31

0.53

iu/ml

1.09

(3044009) aPTT.lupus sensitive (LA screen)

112

2.23

3.55

1.1

1.2

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

217

1.86

3.54

2.0

2.8

63.35

75.39

pmol/l

0.50

190

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

135

1780

0.73

3.42

1.4

1.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

145

1012

1.38

3.42

2.1

2.5

0.80

0.68

e9/l

1.11

135

966

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

229

1710

1.29

3.41

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1282

0.68

3.38

1.4

1.5

53.91

60.89

ug/l

1.21

1282

(3008401) Mugwort IgE Ab [Units/volume] in Serum

307

2377

1.24

3.38

1.1

0.42

0.90

u/ml

3.55

156

930

(3001556) Androgen free Index in Serum or Plasma

2.74

3.35

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3463

35151

0.93

3.33

4.6

4.5

21.12

22.16

3.41

1526

17656

(3051611) Lipemic interference index of Serum or Plasma

220

1641

1.29

3.31

3.4

3.3

14.89

13.09

index

1.00

139

879

(3016750) Collection duration of Urine

127

874

1.40

3.28

1.9

2.2

519.49

495.20

min

1.64

680

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

420

1.58

3.26

2.3

2.5

148.90

127.14

au/ml

—

(44806071) Cardiolipin IgM antibody measurement

196

1.86

3.25

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

316

2470

1.23

3.21

1.1

2.78

3.62

u/ml

0.69

179

1166

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

377

1.60

3.20

1.7

1.5

96.09

140.39

au/ml

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

453

1.55

3.19

1.3

1.7

9.93

9.08

ug/l

0.86

453

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

177

1.90

3.18

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

507

0.51

3.16

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

112

764

1.41

3.07

1.1

1445.41

1487.66

miu/ml

0.17

112

764

(3033942) Copper [Moles/time] in 24 hour Urine

2.80

3.05

1.0

1.2

0.18

0.76

umol/24h

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

222

1.77

3.02

1.4

1.3

75.01

447.02

ng/l

0.58

162

(3001019) Free T4 and TSH panel - Serum or Plasma

684

7470

0.87

3.01

1.9

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

436

3540

1.19

3.00

3.3

3.2

0.80

0.81

nmol/l

0.22

346

2879

(3003694) ABO and Rh group [Type] in Blood

4614

46254

0.94

2.96

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

175

1.87

2.95

1.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

493

1.50

2.94

5.4

6.7

25.38

25.19

mmol/l

0.14

441

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

5.60

2.92

1.0

0.43

0.12

u/ml

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

362

2899

1.20

2.92

1.2

1.1

1.27

1.84

u/ml

1.19

220

1459

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

390

3148

1.19

2.89

1.3

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

159

1160

1.32

2.88

1.8

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

328

1.61

2.87

1.4

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

174

1286

1.30

2.87

1.2

1.3

10.22

8.84

mmol/l

2.90

158

1213

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.40

2.85

1.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

387

3128

1.19

2.83

1.3

1.4

20.86

24.19

u/ml

—

(3052592) Norovirus Ag [Presence] in Stool

301

1.63

2.79

1.2

1.3

—

(4211845) Urine protein measurement

116

814

1.37

2.73

3.6

3.2

—

(3001729) Color of Synovial fluid

119

2.02

2.73

1.4

1.7

—

(3021374) Sirolimus [Mass/volume] in Blood

8.00

2.67

10.2

6.8

8.34

7.05

ug/l

—

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

2.22

2.64

2.3

1.4

6.79

12.86

1.25

(3037692) Legionella sp identified in Specimen by Organism specific culture

594

1.42

2.61

1.2

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2952

26822

1.07

2.57

1.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

122

1.97

2.56

1.0

1.1

204.17

216.07

u/ml

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

685

1.39

2.56

1.9

2.2

39.55

40.08

g/l

0.43

685

(3028308) Erythrocytes [#/volume] in Pleural fluid

242

1893

1.23

2.53

1.4

41420.15

44598.27

e6/l

0.11

135

1055

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

192

1.75

2.52

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.17

2.51

1.1

1.2

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

5.23

2.46

1.2

1.1

277.83

303.27

nmol/l

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.15

2.44

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

268

2128

1.21

2.43

1.4

1.5

6180.45

2533.14

e6/l

0.49

186

1490

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

477

1.45

2.39

3.1

3.3

9.47

8.33

mg/l

0.43

398

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

269

1.61

2.39

1.4

1.6

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

2.06

2.35

2.3

1.3

52.07

36.10

0.89

(3027035) Albumin [Mass/time] in 24 hour Urine

147

1.83

2.34

1.5

1.3

61.50

304.28

mg/24h

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

253

2006

1.21

2.34

1.0

1.1

2.19

3.59

eliau/ml

2.18

932

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

155

1.80

2.30

1.2

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

242

1.63

2.30

2.0

2.7

63.54

58.79

mg/l

0.06

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.13

2.30

1.1

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

125

915

1.31

2.29

2.2

2.8

42.21

37.75

1.85

512

(3007542) Rye IgE Ab [Units/volume] in Serum

2.23

2.26

1.1

1.0

0.86

0.68

u/ml

—

(21494814) CD8 cells/Lymphocytes in Specimen

645

1.37

2.25

1.8

1.9

27.29

31.90

2.66

645

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

215

1689

1.22

2.21

1.1

94.86

96.48

0.37

192

1568

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

208

1.66

2.20

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

109

1.94

2.20

2.4

1.9

—

(3003434) Protein [Mass/volume] in Pleural fluid

297

2410

1.18

2.17

1.4

1.5

33.22

32.58

g/l

0.41

266

2184

(3032743) Legionella sp IgG Ab [Presence] in Serum

103

1.96

2.16

1.3

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

344

2827

1.17

2.16

1.3

1.5

159.70

154.68

au/ml

0.30

827

(4268621) Lupus anticoagulant assay

213

1676

1.22

2.16

2.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

117

1.89

2.14

1.0

1.12

0.82

u/ml

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

278

2247

1.19

2.13

1.1

0.60

1.26

u/ml

3.20

164

1029

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.98

2.11

1.1

1.2

1.78

2.79

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

460

1.42

2.07

1.2

10.72

12.05

pmol/l

0.20

176

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.13

2.06

1.0

0.26

0.03

u/ml

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

105

1.92

2.06

1.3

1.1

—

0.22

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

2.18

2.04

1.1

—

(3006462) Nitrate [Presence] in Urine

102

740

1.32

2.03

3.9

3.3

—

(3033086) Enterovirus Ab [Titer] in Serum

2.67

2.02

1.1

1.0

—

(3019174) dRVVT (LA screen)

113

1.87

2.00

1.1

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

240

1929

1.20

1.98

1.1

3.76

3.01

u/ml

0.27

123

795

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

771

6716

1.11

1.98

2.7

3.6

585.36

1803.05

u/ml

1.74

655

5782

(3000060) B lymphocytes [#/volume] in Blood

379

1.44

1.92

1.3

1.9

0.20

0.71

e9/l

1.27

178

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

332

1.47

1.92

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

108

1.87

1.91

1.2

—

(4133840) Spirometry

465

0.62

1.90

1.2

—

(3033099) Centromere Ab [Titer] in Serum

452

1.40

1.90

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

203

1.61

1.87

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

17037

162101

1.05

1.87

5.9

5.1

4.53

4.71

mmol/l

104.09

15781

151843

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

159

1.69

1.86

2.5

2.9

1.86

1.13

mg/l

1.12

108

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

311

1.48

1.85

1.2

94.25

86.09

0.26

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

528

1.36

1.85

2.0

1.9

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

393

1.42

1.79

1.2

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

298

1.48

1.79

4.7

5.9

8.36

8.51

mmol/l

0.15

298

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

706

1.31

1.78

2.2

2.1

433.94

75.86

ug/min

0.51

161

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

451

1.38

1.76

1.0

0.29

0.61

u/ml

0.80

442

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

315

1.46

1.76

1.1

1.2

90.17

72.18

0.75

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.10

1.76

1.0

0.23

0.01

u/ml

—

(4281824) Cell count and differential, peritoneal fluid

196

2240

0.84

1.71

1.2

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

216

1.56

1.71

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

108

813

1.28

1.69

1.2

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

696

1.30

1.68

1.1

4.4

65.37

1764.40

mg/l

1.86

501

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

187

1.59

1.67

1.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

128

1.72

1.66

2.4

1.9

25.49

23.78

mg/l

0.18

119

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.90

1.65

1.1

—

(3002256) Pathology report gross observation

2560

23489

1.05

1.63

1.3

—

(3050794) Legionella sp Ab [Presence] in Serum

129

1.71

1.62

1.3

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

338

2845

1.14

1.62

1.6

1.7

—

(3042733) HLA Ab [Presence] in Serum

546

0.68

1.59

4.9

5.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

3.03

1.58

1.0

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

107

813

1.26

1.58

1.2

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

109

831

1.26

1.57

1.0

—

(3045788) Cell count panel - Pleural fluid

212

1729

1.18

1.56

1.5

1.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.28

1.55

1.0

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

2.20

1.55

1.0

0.08

0.09

u/ml

—

(3020393) Adenovirus Ag [Presence] in Stool

131

1.68

1.55

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

579

1.31

1.54

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

1.53

0.0

1.1

—

1.26

—

(36303858) Crystals [Presence] in Urine

2.88

1.51

1.0

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

125

1.69

1.50

1.6

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.58

1.50

4.4

5.9

0.31

0.25

mmol/l

—

(3017704) Immunofixation for Urine

118

914

1.24

1.49

1.4

1.7

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

123

0.39

1.49

1.0

1.2

93.00

66.39

ug/l

—

123

(3005532) Lymphocytes/Leukocytes in Pleural fluid

558

1.31

1.48

1.3

1.4

57.22

64.52

1.11

460

(3014133) Dog dander IgE Ab [Units/volume] in Serum

247

2050

1.16

1.48

1.1

2.51

3.23

u/ml

0.47

142

949

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

618

1.29

1.46

2.4

2.9

0.60

0.61

mmol/l

0.75

618

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

517

4499

1.10

1.44

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

202

1654

1.17

1.44

1.3

732.96

456.59

u/l

0.55

187

1576

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

1.92

1.42

1.9

1.3

1.11

1.69

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

681

1.27

1.41

1.3

1.2

—

(3045142) Bone marrow Pathology biopsy report

178

2009

0.85

1.40

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

134

0.43

1.39

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

100

1.73

1.34

1.3

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

199

1639

1.17

1.34

1.3

—

(40768806) Pleura Pathology biopsy report

215

1786

1.16

1.31

1.5

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

435

1.32

1.31

1.4

30.25

18.97

2.10

393

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

16912

161167

1.04

1.29

5.7

5.0

1.42

1.51

mmol/l

138.33

15563

150168

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.33

1.28

1.0

2.96

1.97

u/ml

—

(3020874) Milk IgE Ab [Units/volume] in Serum

113

891

1.22

1.26

1.0

0.60

1.53

u/ml

1.11

247

(3036071) Salmonella sp Ab [Titer] in Serum

455

1.31

1.25

1.2

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

534

4697

1.09

1.24

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.40

1.23

2.3

2.8

1.87

2.17

mu/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

431

1.31

1.23

1.8

2.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.19

1.22

1.3

1.0

29.17

70.82

umol/24h

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

415

1.32

1.22

1.3

25.57

26.98

g/l

0.28

328

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

466

1.30

1.21

1.4

1.7

—

218.13

iu/ml

—

(3009871) Measles virus Ab [Titer] in Serum

712

0.77

1.21

1.6

3396.92

3394.75

titre

0.00

122

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

603

1.26

1.19

1.2

1.8

102492.27

22832.55

u/ml

0.42

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

119

1.61

1.19

1.5

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

579

5124

1.09

1.18

1.4

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

176

1455

1.16

1.17

3.1

3.0

16.46

49.24

mg/l

3.49

126

1006

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.07

1.16

1.0

1.3

1.50

1.33

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

105

1.64

1.16

1.0

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

1.16

0.0

1.2

—

(3020650) Glucose [Presence] in Urine

539

1.26

1.13

2.2

1.5

0.08

0.03

estimate

0.39

539

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

1.13

0.0

1.4

—

174988.89

—

(3047189) Immunofixation for 24 hour Urine

100

790

1.22

1.12

1.6

1.9

—

(3035880) pH of Pleural fluid

110

878

1.20

1.11

1.3

7.35

7.43

2.11

632

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

127

1029

1.19

1.10

1.1

18.47

19.63

u/ml

0.17

404

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.97

1.09

1.0

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.97

1.09

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.88

1.09

1.2

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

100

1.63

1.07

1.0

0.10

0.28

u/ml

0.93

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

268

0.64

1.07

4.2

5.8

—

4750.94

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.17

1.07

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

735

1.21

1.06

1.2

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

307

3255

0.90

1.02

3.3

3.6

40.00

41.81

u/ml

0.08

298

3144

(3036782) Glucose [Moles/volume] in Pleural fluid

198

1676

1.13

0.99

1.3

6.42

6.32

mmol/l

0.17

183

1563

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.68

0.99

10.8

7.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

157

1.47

0.99

1.5

2.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.18

0.98

1.4

1.0

—

(3034092) Cytoplasmic Ig cells/cells in Blood

203

0.61

0.96

15.4

7.9

0.19

0.21

0.32

203

(4035726) Immunohistochemistry procedure

1604

16022

0.96

1.3

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

182

1.42

0.96

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

102

823

1.19

0.96

2.8

2.2

198.41

206.58

u/l

0.60

102

813

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

590

0.78

0.95

1.5

1.6

0.47

1.56

u/ml

—

138

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

273

1.34

0.94

1.0

1.1

23.38

28.31

iu/ml

0.28

273

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

151

1.46

0.94

1.3

1.8

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

315

1.31

0.94

1.3

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

113

1.53

0.90

1.2

1.1

—

(3000285) Sodium [Moles/volume] in Blood

326

1.30

0.90

1.3

137.97

138.25

mmol/l

0.13

277

(4038314) Semen analysis, post vasectomy

1.92

0.89

1.1

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.83

0.86

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

203

1745

1.12

0.83

1.1

1.0

0.38

0.26

u/ml

0.25

507

(21494434) Karyotype in Bone marrow

176

1501

1.13

0.82

1.1

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

135

0.57

0.82

1.1

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

468

1.23

0.82

1.3

42.70

214.76

ug/l

2.01

255

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.74

0.82

1.0

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

478

1.22

0.81

1.3

1.4

2.21

2.74

0.26

404

(40757373) Influenza virus identified in Isolate

290

1.29

0.79

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

609

6199

0.94

0.79

1.4

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

182

1.37

0.78

1.0

0.04

0.64

u/ml

0.58

113

(3026051) Granulocytes/Leukocytes in Pleural fluid

376

1.25

0.78

1.2

1.4

30.56

22.26

0.88

307

(3025130) Human papilloma virus identified in Specimen

269

2363

1.09

0.75

1.9

1.8

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

184

1.36

0.74

1.0

1.1

22.98

19.88

u/l

0.31

118

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.66

0.74

1.1

0.02

0.04

u/ml

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

177

0.65

0.74

1.8

3.0

35.25

44.54

0.92

177

(3011335) Digoxin [Mass/volume] in Serum or Plasma

128

0.60

0.73

1.9

2.1

0.63

0.66

ug/l

—

128

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

432

1.22

0.73

1.1

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

134

1453

0.88

0.73

1.1

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

152

1.39

0.73

1.2

6.34

6.22

mmol/l

0.32

152

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

176

0.65

0.72

3.7

6.1

9.33

8.36

0.21

176

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

128

1.42

0.72

1.5

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

442

1.22

0.71

1.9

89.89

34.31

u/l

0.75

408

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

390

1.23

0.71

2.4

1938.54

381.79

ug/l

0.71

390

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

461

4151

1.07

0.70

1.3

174.80

214.93

miu/ml

1.78

164

1887

(3015076) Soybean IgE Ab [Units/volume] in Serum

780

1.16

0.69

1.0

0.36

0.81

u/ml

0.40

150

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.68

0.68

1.1

1.0

173.71

229.38

u/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

435

0.79

0.68

1.2

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

707

0.84

0.67

30.3

108.62

112.35

ug/l

0.16

600

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

126

1071

1.13

0.67

5.9

7.0

10.46

73.30

ug/l

1.46

677

(3010937) Rubella virus Ab [Presence] in Serum

0.54

0.67

1.0

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.49

0.66

1.2

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

677

1.16

0.66

2.0

1.9

579.64

2465.25

e6/l

0.90

446

(40768441) Liver Pathology biopsy report

147

1267

1.11

0.63

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

236

0.73

0.62

1.9

1.8

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.65

0.61

1.2

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

134

0.64

0.60

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.59

0.0

1.1

—

0.49

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

707

0.85

0.59

1.3

1.2

9.57

11.06

mm/h

0.69

707

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.58

0.0

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

427

1.19

0.58

1.3

1.4

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

108

0.62

0.58

1.0

—

(40768795) Lymph node Pathology biopsy report

181

1897

0.91

0.57

1.2

—

(3013762) Body weight Measured

1.69

0.57

1.2

1.1

—

(3024932) HLA-DR beta [Type]

507

0.83

0.56

1.2

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

431

1.18

0.54

1.1

1.0

9.93

7.32

u/ml

0.35

274

(3007733) Chloride [Moles/volume] in Urine

1.56

0.53

1.0

1.1

103.67

80.22

mmol/l

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

196

1.27

0.53

1.0

104.14

81.18

ug/l

1.46

144

(3023383) Lactate [Moles/volume] in Pleural fluid

530

1.16

0.53

1.2

1.3

4.07

3.22

mmol/l

0.97

491

(40762887) Creatinine [Moles/volume] in Blood

129

1.34

0.51

1.7

1.5

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.48

0.50

1.2

1.1

27.38

33.01

mg/24h

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

138

1.32

0.50

1.1

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.50

0.50

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

355

1.19

0.50

1.7

2.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

149

1307

1.09

0.49

1.3

16.96

14.30

u/l

0.37

138

1192

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

130

1369

0.91

0.48

1.2

—

(44806420) Estimation of glomerular filtration rate

213

1907

1.07

0.45

2.8

2.5

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.43

0.45

1.0

10.05

3.28

u/ml

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

930

0.90

0.44

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

135

0.71

0.44

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

116

1.32

0.44

4.9

5.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

133

1.30

0.44

1.1

1.0

—

(40768793) Breast Pathology biopsy report

505

4641

1.04

0.43

1.4

1.3

—

(40762814) Titanium [Mass/volume] in Blood

290

1.19

0.43

2.2

2.5

3.67

3.92

ug/l

0.15

111

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.65

0.42

4.0

3.4

—

(3034426) Prothrombin time (PT)

497

1.14

0.42

1.3

1.2

27.66

28.44

0.50

497

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

163

1684

0.93

0.41

2.2

2.4

41.60

27.16

iu/ml

0.70

203

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.41

0.0

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

447

0.86

0.40

1.0

1.2

1228.57

977.42

titre

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.40

0.0

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

284

1.18

0.40

1.7

1.6

109.14

109.48

ug/l

0.01

237

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

221

1995

1.06

0.39

1.3

7.54

7.40

mmol/l

0.30

191

1727

(3038177) Helicobacter pylori Ab [Presence] in Serum

285

2594

1.05

0.38

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

857

1.10

0.38

1.0

2.06

1.47

u/ml

0.14

169

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.35

0.38

1.0

1.5

—

(40763590) HLA-DQ beta [Type]

1.33

0.37

1.0

—

(40760409) HLA-A [Type] by High resolution

1.31

0.37

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.31

0.37

1.0

—

(40760410) HLA-B [Type] by High resolution

1.31

0.37

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.31

0.37

1.1

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.39

0.36

1.0

1.1

320.00

294.86

nmol/l

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.34

0.36

1.0

—

(3013862) HLA-DP [Type]

1.27

0.36

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.44

0.35

9.3

9.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

226

1.19

0.35

3.9

5.6

47.22

39.19

ug/min

0.28

176

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

213

0.81

0.34

1.1

1.0

10.21

13.55

u/ml

0.20

213

(3026692) Albumin [Mass/volume] in Peritoneal fluid

470

1.12

0.34

1.4

1.3

12.10

13.63

g/l

0.60

360

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

690

0.90

0.33

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

210

1908

1.06

0.32

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.28

0.32

1.3

1.2

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

246

1.17

0.32

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

291

1.15

0.32

4.7

7.2

10.92

10.56

0.31

291

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

591

1.10

0.32

1.8

1.7

3027.83

14057.81

e6/l

1.80

293

(3024471) HLA-A [Type]

517

0.89

0.31

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

167

1.21

0.31

1.9

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

160

1629

0.94

0.31

1.1

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.72

0.31

1.0

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.24

0.29

1.0

1.6

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

161

1458

1.06

0.29

1.8

1.7

3.70

4.00

mg/l

0.65

151

1411

(3041918) Cholesterol [Moles/volume] in Pleural fluid

350

1.12

0.27

1.2

1.53

1.68

mmol/l

0.49

222

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

423

1.11

0.27

9.3

8.5

6.07

5.96

kpa

0.38

372

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

152

1.20

0.27

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

349

0.88

0.27

1.7

3.6

117.63

98.47

ng/l

—

133

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.20

0.26

1.3

1.0

6.12

1.19

u/ml

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.69

0.26

1.0

—

(40765096) Chromosome analysis panel by Banding

508

1.10

0.25

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.22

0.25

1.0

0.04

0.15

u/ml

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

1.26

0.22

3.8

5.3

3.02

5.68

mg/l

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

292

2709

1.03

0.22

1.8

1.6

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.21

0.0

2.5

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.21

0.0

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.21

0.0

5.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

531

0.92

0.20

1.0

1.2

—

(40758292) HTLV I+II Ab panel - Serum

321

0.90

0.20

1.2

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

294

1.11

0.20

1.3

1.2

1.54

1.64

mmol/l

0.03

192

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.20

0.0

1.1

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.20

0.0

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

113

1.19

0.19

1.0

0.05

0.11

u/ml

—

(3000963) Hemoglobin [Mass/volume] in Blood

18366

176362

0.99

0.19

36.7

23.1

132.14

134.66

g/l

107.65

18189

174454

(3004446) Plasmodium sp identified in Blood by Light microscopy

140

1.16

0.19

2.4

2.6

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

150

1.15

0.18

1.2

88.03

106.69

ug/l

0.37

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.18

0.18

1.0

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

116

0.83

0.17

1.6

1.9

29.80

18.95

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.14

0.17

1.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.75

0.17

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

372

1.08

0.16

9.0

8.4

5.94

5.65

kpa

0.34

372

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1049

10192

0.99

0.16

3.1

3.9

96.52

60.77

u/ml

0.57

1005

9883

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4527

43660

0.99

0.16

5.4

5.5

2.14

3.31

ug/l

4.93

4005

39780

(3026361) Erythrocytes [#/volume] in Blood

18365

176323

0.99

0.16

36.4

22.9

4.40

4.47

e12/l

78.55

18005

171814

(3014891) Appearance of Pleural fluid

216

1.11

0.15

1.7

1.5

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.10

0.15

1.5

1.3

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

244

1.10

0.15

1.4

8.36

12.97

0.89

123

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

552

0.94

0.15

1.1

1.2

—

(3048879) Bone marrow aspiration report

477

1.07

0.15

1.5

1.9

—

2.00

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

18365

176314

0.99

0.15

37.0

23.3

39.62

40.64

19.09

18177

174293

(40758358) Immune stain study

1.09

0.14

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.80

0.14

1.0

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

18365

176310

0.99

0.14

36.3

22.9

91.40

91.21

7.17

18179

174368

(3035941) MCH [Entitic mass]

18364

176300

0.99

0.14

36.2

22.8

30.28

30.31

1.57

18176

174361

(3010813) Leukocytes [#/volume] in Blood

18370

176344

0.99

0.13

36.5

23.0

7.00

6.64

e9/l

75.66

18013

171817

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

819

1.04

0.12

1.2

1.3

143.90

168.14

pmol/l

1.00

819

(4212803) Bone marrow aspirate examination

137

1.12

0.11

1.1

—

(3044007) Cell count panel - Peritoneal fluid

577

1.05

0.11

2.0

1.8

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

210

0.91

0.11

1.2

1.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

129

1.12

0.10

7.9

5.6

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.09

0.09

1.0

0.01

0.07

u/ml

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

260

1.07

0.09

1.0

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

267

0.93

0.09

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

257

0.93

0.09

2.4

2.7

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

261

1.07

0.09

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

261

1.07

0.09

1.0

1.2

—

(3007461) Platelets [#/volume] in Blood

18364

176246

0.99

0.08

36.4

23.0

258.74

251.83

e9/l

37.09

18062

172365

(40768446) Kidney Pathology biopsy report

637

0.96

0.08

1.5

1.7

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.03

0.08

1.0

1.1

0.01

1.31

u/ml

—

(3009677) Dengue virus Ab [Presence] in Serum

0.79

0.08

1.0

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

187

1.08

0.08

13.0

1.3

7.78

7.14

mmol/l

0.53

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

118

0.89

0.08

1.2

1.1

93.09

96.00

titre

0.05

118

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

186

0.93

0.07

1.2

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.87

0.06

1.5

1.3

419.88

309.11

umol/24h

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

807

1.02

0.05

6.3

5.2

3144.00

6847.05

u/ml

0.25

113

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

219

1.05

0.04

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

144

0.93

0.04

2.1

2.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

173

0.94

0.04

1.1

1.2

0.09

0.44

u/ml

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

550

0.98

0.04

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

115

1119

0.99

0.04

1.1

1.2

89.86

82.63

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

461

0.98

0.02

1.1

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

336

1.03

0.02

1.1

1.9

1.41

2.65

ug/l

3.48

211

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

499

0.98

0.02

1.7

7.60

1399.76

pmol/l

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

445

4251

1.00

0.02

1.5

1.4

171.62

159.41

pmol/l

0.14

434

4162

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

151

0.95

0.02

1.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.07

0.01

4.5

4.8

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

467

0.99

0.01

1.4

1.5

34.99

37.50

nmol/l

0.13

420

(3026726) Creatinine [Moles/volume] in Specimen

130

0.96

0.00

3.4

2.5

539.77

323.31

umol/l

0.34

124

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

283

1.02

0.00

1.2

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

245

1.02

0.00

9.7

11.1

6.43

5.01

mmol/l

0.44

245

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

174

0.99

0.00

2.6

2.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.04

0.00

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

126

1204

1.00

0.00

1.3

1.6

2.51

4.92

ug/l

2.17

946

(3030703) Everolimus [Mass/volume] in Blood

0.00

0.0

23.4

—

5.47

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.88

0.00

1.0

—

(36305197) Thyroglobulin and thyroperoxidase Ab panel - Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.01

-0.00

1.0

1.1

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

7.8

—

(3039542) Porphyrins [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.2

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.91

-0.00

1.0

1.2

—

23.89

—

(3022475) Manganese [Moles/volume] in Blood

0.96

-0.00

1.6

1.3

0.14

0.15

umol/l

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.91

-0.00

33.7

14.7

105.50

105.41

g/l

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

-0.00

0.0

1.4

—

19.77

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: MRI_NONSEL – Non-selective monoamine reuptake inhibitors

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Non-selective monoamine reuptake inhibitors

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Non-selective monoamine reuptake inhibitors (MRI_NONSEL)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints